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Pyruvate carboxylase (PC; EC 6.4.1.1) ostensibly links carbohydrate and lipid 
metabolism by supplying oxaloacetate (OAA) from the carboxylation of pyruvate. The 
OAA pool is necessary in maintaining the anaplerotic supply of carbons to the TCA 
cycle, and to promote the complete oxidation, to CO2, of acetyl-CoA. The actions of PC 
in supplying OAA are critical during periods of increased cellular lipid load, including 
the negative energy balance experienced by periparturient dairy cows. The bovine PC 
gene contains three promoter sequences, with products of the proximal promoter (PCP1) 
being specific to glucogenic and lipogenic tissues. Previous work links control of bovine 
PC mRNA expression to nonesterified fatty acids (NEFA), but the direct effects of 
saturated and unsaturated fatty acids on PC mRNA expression and subsequent fatty acid 
metabolism were unclear. The central hypothesis of this dissertation is that the ratio of 
the most prevalent circulating saturated and unsaturated fatty acids in dairy cows 
regulates PC flux and subsequent fatty acid metabolism. The objectives of this 
dissertation were, first, to evaluate the response of PC mRNA to the copresence of the 
most abundant circulating saturated and unsaturated fatty acids in periparturient dairy 
cows. Second, to determine the direct effects of these saturated and unsaturated fatty  
xvi 
acids, and their combinations, on the cellular oxidation of fatty acids, and the potential 
relationship to PC, and third, to examine the effects of the copresence of saturated and 
unsaturated fatty acids on the transcriptional activity of bovine PCP1. 
Bovine PC mRNA expression was first examined, in response to copresence of 
saturated and unsaturated fatty acids, in a bovine kidney cell line and in bovine primary 
hepatocytes. Both C16:0 or C18:0 alone significantly depressed PC mRNA in bovine 
kidney cells. Inclusion of unsaturated C18:3n-3 cis restored PC expression to levels 
similar to control in bovine kidney cells. Data from bovine primary hepatocytes displayed 
a similar numerical pattern in response to fatty acid combinations, although means did 
not differ. However, incubation with C18:3n-3 cis alone resulted in nearly two-fold 
increase in PC mRNA expression, compared to PC mRNA expression after control or 
saturated fatty acid exposure. Treatment with monounsaturated C18:1n-9 cis did not alter 
PC mRNA expression in either cell model. Results indicate that C18:3n-3 cis is a potent 
alleviator of saturated fatty acid-induced depression of PC mRNA expression. 
To determine the impact of alterations in PC mRNA expression on cellular 
metabolism of fatty acids, the flux of radiolabeled C16:0 to CO2 or to acid-soluble 
metabolites, including ketone bodies, was analyzed after pretreatment of bovine kidney 
cells with combinations of saturated and unsaturated fatty acids which are most prevalent 
in periparturient dairy cows. Prior exposure to either C16:0 or C18:0 alone significantly 
depressed both complete and partial oxidation compared to exposure to C18:3n-3 alone. 
Data for complete oxidation of radiolabeled C16:0 to CO2 were correlated (r = 0.63; P < 
0.05) with PC mRNA expression, suggesting a potential relationship between PC flux 
and subsequent fatty acid metabolism. Oxidation of radiolabeled C16:0 to CO2 was also 
xvii 
correlated (r = 0.80; P < 0.05) to expression of cytosolic phosphoenolpyruvate 
carboxykinase (PCK1). The data indicate that although PC is regulated by fatty acids and 
in turn modulates the oxidation of fatty acids, the concomitant increase in PCK1 may 
oppose these effects by pulling carbon from the OAA pool toward gluconeogenesis. 
Factors remain to be identified that permit increased PC flux while maintaining, but not 
enhancing, PCK1 flux.  
The role of bovine PCP1 in regulating the expression of PC mRNA in response to 
the copresence of saturated and unsaturated fatty acids prevalent in periparturient dairy 
cows was evaluated using bovine PCP1 ligated to a Firefly luciferase reporter and 
transiently transfected into bovine kidney cells. Bovine PCP1 activity increased in 
response to either C16:0 or C18:3n-3 cis, and combinations of those fatty acids, 
indicating a dominant role of C18:3n-3 cis in controlling bovine PCP1 activity. 
Truncations of bovine PCP1 indicate a region responsive to fatty acids located between   
-773 to -494 bp (PCP1(-773_+3)) relative to transcription start site (TSS), as activity in 
response to fatty acid greatly diminished with truncation of this region. In silico analysis 
of bovine PCP1 indicates several transcription factor binding site consensus sequences, 
including peroxisome proliferator activated receptor (PPAR) α and sterol regulatory 
element binding proteins (SREBP) sites, that are candidate response elements for control 
by C18:3n-3 cis and C16:0 or C18:0. Results indicate a dominant role of C18:3n-3 cis to 
signal through bovine PCP1(-773_+3) containing a PPARα binding site. A SREBP binding 
site within bovine PCP1(-773_+3) is a candidate for saturated fatty acid responsiveness 
within this promoter region.  
xviii 
Together, these data indicate control by saturated and unsaturated fatty acids 
prevalent in periparturient bovine on PC mRNA expression, regulated through the PC 
proximal promoter, and in determining subsequent cellular fatty acid metabolism. 
Responsiveness of bovine PCP1 to saturated and unsaturated fatty acids may be mediated 
through identified putative binding sites. The cellular oxidative capacity, dependent upon 
the pool of OAA generated by PC, can help determine the response to physiological 
factors, including fatty acids, which increase during metabolically stressful periods in 
dairy cows.  
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CHAPTER 1.  LITERATURE REVIEW 
INTRODUCTION 
 
First discovered for its role in gluconeogenesis in chicken liver (Utter and Keech, 
1960), pyruvate carboxylase (PC; EC 6.4.1.1) is a mitochondrial enzyme central to 
several metabolic pathways. Pyruvate carboxylase is responsible for the irreversible, 
ATP-dependent carboxylation of pyruvate to oxaloacetate (OAA; Utter and Keech, 
1960). Oxaloacetate supply by PC is inextricably linked to the activity of the 
tricarboxylic acid (TCA) cycle, which functions to oxidize acetyl-CoA to CO2 and 
provide intermediates for several other biological pathways. The flux of carbons into, and 
maintenance of the TCA cycle biological intermediates, is referred to as anaplerosis 
(Kornberg, 1966; Owen et al., 2002). The anaplerotic role of PC in catalyzing OAA 
synthesis from pyruvate, is therefore evident. The reciprocal pull of carbons away from 
the TCA cycle, or cataplerosis, links products of the TCA cycle to several biosynthetic 
pathways, including fatty acid synthesis, gluconeogenesis, and glyceroneogenesis (Owen 
et al., 2002). Because the TCA cycle cannot serve as a carbon sink, cataplerotic enzymes, 
including phosphoenolpyruvate carboxykinase (PCK; EC 4.1.1.32), become especially 
critical during periods of increased energy intake (Owen et al., 2002). Without increased  
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cataplerotic pull, the anaplerotic action of PC could function to increase the oxidative 
capacity of the TCA cycle, increasing the oxidation of acetyl-CoA.  
 Regulation of PC by circulating fatty acids has been extensively explored in both 
human and murine models (Jitrapakdee et al., 2008; Gray et al., 2014), and recently 
explored in bovine (White et al. 2011b,c; White et al., 2012). A direct relationship 
between PC activity and influences of specific fatty acids has yet to be fully elucidated. 
This review will focus on the regulation and anaplerotic roles of PC, examine the 
potential influences of circulating fatty acids, and stress the significance of these roles in 






 The mammalian PC enzyme, found in the mitochondrial matrix, consists of four 
identical subunits, each of approximately 120 – 130 kDa. These subunits are arranged as 
dimers of dimers in a homotetrameric structure. The PC enzyme is only active in this 
tetrameric structure (Jitrapakdee et al., 2008; Gray et al., 2014). Similar to other biotin-
dependent enzymes, PC contains three functional domains: an N-terminal domain with a 
biotin carboxylation site, a central domain with a carboxyltransferase site, and a C-
terminus domain containing the biotin carboxyl carrier protein unit (St. Maurice et al., 
2007). A prosthetic biotin group is covalently bound to a specific lysine residue within 
the carrier protein unit (Jitrapakdee and Wallace, 1999). Pyruvate carboxylase shows a 
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high degree of structural similarity to other biotin-dependent enzymes, including 
propionyl-CoA carboxylase (PCC; EC 6.4.1.3), and acetyl-CoA carboxylase (ACC; EC 
6.4.1.2; Jitrapakdee et al., 2008).  
 
Enzyme function 
 Conversion of pyruvate to OAA by PC occurs over two spatially separate enzyme 
subsites. This reaction is catalyzed in two steps with biotin acting as the carboxyl carrier. 
The first, ATP-dependent step involves carboxylation of biotin with a CO2 from HCO3
-, 
via the formation of a carboxyphosphate intermediate (Attwood, 1995; Jitrapakdee and 
Wallace, 1999; Gray et al., 2014). The carboxybiotin group is then transferred to the PC 
carboxyltransferase site where the carboxyl group is transferred from carboxybiotin to 
pyruvate, resulting in OAA and a regeneration of the biotin cofactor (Jitrapakdee and 
Wallace, 1999; Gray et al., 2014). Requirements for ATP, acetyl-CoA, and Mg2+, for the 
reaction to proceed were identified very early on (Utter and Keech, 1960). The role of 
Mg2+ as an essential cofactor was later confirmed through several kinetic studies to 
identify Mg2+ binding sites (Attwood and Graneri, 1992). Necessity of acetyl-CoA as an 
allosteric activator of PC is now well established (review by Adina-Zada et al., 2012). 
Binding of acetyl-CoA drastically alters both the structure and catalytic activity of PC 
through stabilization of the tetrameric structure of the enzyme and enhancement of 
substrate binding to HCO3
- (Adina-Zada et al., 2012). The major influence of acetyl-CoA 
is only the first partial reaction carried out by PC, and the allosteric binding site of acetyl-
CoA between the different domain sites has been identified (St. Maurice et al., 2007).  
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ROLE OF PYRUVATE CARBOXYLASE IN METABOLISM 
 
Anaplerotic Roles of Pyruvate Carboxylase 
 Pyruvate carboxylase was initially identified, along with fructose-1,6-
bisphosphtase (F1,6BPase; EC 3.1.3.11), glucose-6-phosphatase (G6Pase; EC 3.1.3.9), 
and PCK, as one of the four primary gluconeogenic enzymes (Utter and Keech, 1960). 
More recently, PC has been described as the “archetypical anaplerotic enzyme” for its 
fundamental role in replenishing OAA supply to the TCA cycle (Owen et al., 2002). The 
limiting factor for TCA cycle capacity is the pool of OAA, and while this pool is utilized 
for several biological endpoints, discussed below, the pull of carbon intermediates out of 
the TCA cycle must be concurrently coupled with OAA supply. Any biochemical 
pathway that begins with an intermediate of the TCA cycle relies on the anaplerotic 
replenishment of TCA cycle intermediates, in part by PC, to promote flow through the 
pathway (Figure 1.1).  
 
Overview of Tricarboxylic acid cycle  
The TCA cycle is common to all aerobic organisms and generates energy through 
the oxidation of carbon fuel sources to generate reducing equivalents, which will in turn 
be utilized to generate ATP through oxidative phosphorylation. The essentiality of the 
TCA cycle in many biochemical pathways across a variety of organisms illustrates its 
conservation through evolution. In eukaryotes, acetyl-CoA, produced from the catabolism 
of amino acid carbons, carbohydrates, and lipids, is oxidized in the mitochondria, 
yielding three equivalents of NADH, one equivalent of FADH2, and one equivalent of 
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GTP per acetyl-CoA equivalent. The NADH and FADH2 produced are subsequently 
utilized, through oxidative phosphorylation, to generate ATP. The initial reaction of the 
TCA cycle involves the condensation of 4-carbon OAA with 2-carbon acetyl-CoA and is 
catalyzed by citrate synthase (EC 2.3.3.1; Remington, 1992). This is the first of three 
exergonic reactions of the TCA cycle. Binding of OAA to citrate synthase induces a 
conformational change in the enzyme, only then exposing the binding site for acetyl-CoA 
(Remington, 1992). The need for the pool of OAA to drive the reaction is again 
emphasized here. Subsequent dehydrogenation and decarboxylation reactions yield the 




Figure 1.1. Anaplerotic and cataplerotic pull of oxaloacetate (OAA) by pyruvate 
carboxylase (PC) and phosphoenolpyruvate carboxykinase (PCK). Adapted from Burgess 
et al., 2004. The oxidative capacity of the tricarboxylic acid (TCA) cycle is dependent 
upon the ratio of acetyl-CoA to oxaloacetate (OAA). Activation of PC promotes 
anaplerotic pull of carbons to OAA synthesis and promotes TCA oxidative capacity. 
Dihydroxyacetone phosphate, DHAP; fructose-6-phosphatase, F6P; fructose 1, 6-




























Regulation of Tricarboxylic acid cycle  
Both entry into, and rate of, the TCA cycle are tightly controlled through the 
actions of several enzymes which are regulated, in large part, by the cellular 
concentrations of ATP and NADH. The first of three exergonic steps of the TCA cycle, 
catalyzed by citrate synthase, was described above. The remaining exergonic steps 
involve the enzymes isocitrate dehydrogenase (EC 1.1.1.42) and α-ketoglutarate 
dehydrogenase (EC 1.2.4.2; Berg et al., 2002). Substrate availability for citrate synthase 
of either OAA or acetyl-CoA can vary under different metabolic circumstances. Increases 
in the ratio of the concentrations of NADH and NAD+ can lead to negative feedback of 
both isocitrate dehydrogenase and α-ketoglutarate dehydrogenase, as can increases in 
ATP levels (Williamson and Cooper, 1980; Berg et al., 2002). An increased NADH to 
NAD+ ratio would also indicate a decreased concentration of OAA, decreasing flux into 
the initial cycle reaction. Additionally, ADP acts as an allosteric activator of isocitrate 
dehydrogenase by enhancing substrate affinity (Berg et al., 2002). Such tight allosteric 
regulations by reaction products allows for acute and rapid response to energy status 
changes within the cell. Deficiency of α-ketoglutarate dehydrogenase is a very rare 
autosomal recessive trait that presents with hypotonia, encephalopathy, and failure to 
thrive; no specific treatment is available (Pithukpakorn, 2005). Such dramatic alterations 
to metabolism illustrate the central role of this enzyme and the TCA cycle. The role of 
PC in several aberrant metabolic systems is discussed in depth in subsequent sections.  
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Substrates of Tricarboxylic acid cycle 
Substrate flow into the TCA cycle increases during the fed state when metabolism 
of glucose to pyruvate is increased. During the postprandial period, glucose enters 
hepatocytes via the GLUT2 glucose transporter and is immediately phosphorylated by 
glucokinase to glucose-6-phosphate. Gluconeogenesis and the cataplerotic role of 
pyruvate carboxylase will be discussed in detail below. In brief, glucose-6-phosphate can 
either be stored as glycogen or metabolized to pyruvate, potentially supplying this 
substrate to PC for carboxylation to OAA (Rui, 2014). Linking cytosolic pyruvate 
metabolism to the TCA cycle, the mitochondrial pyruvate carrier functions to transport 
pyruvate from the mitochondrial intermembrane space to the mitochondrial matrix (Gray 
et al., 2014; Patel et al., 2014). During the fed state, at least in nonruminants, most 
pyruvate (with NAD+) is converted by the pyruvate dehydrogenase complex (PDC) to 
acetyl-CoA, NADH, and CO2, with generated acetyl-CoA subsequently entering the TCA 
cycle (Berg et al., 2002). Acetyl-CoA may also be utilized in other biochemical reactions, 
including generation of acetylcholine, cholesterol formation, or lipogenesis. The PDC is 
very tightly regulated by the energy status by the cell and is inhibited during high energy 
status, when acetyl-CoA, ATP, or NADH levels increase (Gray et al., 2014). Regulation 
of PDC occurs through transcriptional abundance of the proteins comprising the complex, 
or acutely through phosphorylation and dephosphorylation by pyruvate dehydrogenase 
kinases (PDK) and pyruvate dehydrogenase phosphatases (PDP), respectively. 
Phosphorylation of specific residues on PDC subunits by PDK allow for rapid 
downregulation of PDC in response to cellular energy levels. For example, during 
fasting, activity of PDC can be repressed to promote the flux of pyruvate to other cellular 
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fates. Pyruvate dehydrogenase phosphatase functions to dephosphorylate and activate 
PDC to increase the flux of acetyl-CoA to the TCA cycle. Pyruvate dehydrogenase 
phosphatase is activated by insulin and AMP, and inhibited by acetyl-CoA, ATP, and 
NADH (Gray et al., 2014).  
Because the supply of both acetyl-CoA and OAA regulate substrate availability 
for PC, both pools must be taken into consideration when investigating the anaplerotic or 
cataplerotic roles of PC. The anaplerotic activity of PC, through the generation of OAA 
from pyruvate, serves to offset the cataplerotic pull of carbons from the TCA cycle. The 
ratio of acetyl-CoA to OAA must remain equal if activity of the TCA cycle to completely 
oxidize acetyl-CoA is to be maintained (White, 2015). The circulating fatty acid profile 
both supplies acetyl-CoA from fatty acid β-oxidation, and serves as signaling molecules 
to regulate both gene expression and cellular metabolism. Increases in the oxidative 
capacity of the TCA cycle, through increased PC flux would allow lactating dairy cows 
to better cope with the increased plasma nonesterified fatty acid (NEFA) load 
experienced at calving.  
 
Cataplerotic Roles of Pyruvate Carboxylase 
 A primary role of PC involves supply of OAA for conversion to 
phosphoenolpyruvate (PEP) by PCK (Figure 1.1). This cataplerotic pull of carbons away 
from the TCA cycle and into other biochemical pathways in necessary to avoid the 
excessive accumulation of ions in the mitochondrial matrix. Primary cataplerotic 
pathways in which PC is critical include gluconeogenesis and synthesis of fatty acids.  
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Gluconeogenesis: Overview and Regulation 
 Gluconeogenesis denotes the production of glucose, de novo, from non-
carbohydrate precursors, including glucogenic amino acids, glycerol, lactate, and 
propionate. Gluconeogenesis is critical in providing glucose to tissue with an obligatory 
requirement for glucose, including the brain, erythrocytes, and mammary gland 
(Aschenbach et al., 2010). Glucose supply from gluconeogenesis is critical during periods 
when both dietary glucose and glycogen stores are expended, such as fasting or intense 
exercise, in nonruminants, or at all times in ruminant animals (Aschenbach et al., 2010). 
Liver and kidney are the major gluconeogenic tissues (Exton, 1972; Berg et al., 2002), 
with recent research revealing small intestine as a third site of gluconeogenesis with 
propionate, glycerol, and glutamine serving as gluconeogenic substrates (Croset et al., 
2011; De Vadder et al., 2014). The relative contribution of small intestine to whole-body 
glucose production is still nominal in comparison to liver and kidney production. While 
the process of gluconeogenesis does share the same pathway with glycolysis, the 
thermodynamic barriers of irreversible reactions in glycolysis necessitate a separate set of 
enzymes and leads to more than just a simple reversal of the steps to glycolysis.  
 Cellular transport systems allow entry of gluconeogenic precursors, namely 
alanine, glycine, lactate, or serine, into the cytosol for conversion to pyruvate. In what is 
the most widely known role for PC, pyruvate is converted to OAA in the mitochondria 
(Berg et al., 2002), the first step in the conversion of pyruvate to PEP. This irreversible 
step to gluconeogenesis requires two enzymes; the first, PC, and the second, PCK. The 
decarboxylation of OAA to PEP by PCK requires GTP and is an endothermic process 
(Berg et al., 2002). There are two isoforms of PCK; PCK1 is compartmentalized to the 
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cytosol and PCK2 to the mitochondria (Hanson and Garber, 1972). The two PCK 
isoforms are encoded by separate genes, but have highly similar kinetic characteristics 
and in most species, including ruminants, activity of the two forms is equal (Hanson and 
Garber, 1972; Hanson and Reshef, 1997). For conversion of OAA to PEP by PCK1, 
OAA must first be transported to the cytosol. Because OAA cannot cross the 
mitochondrial membrane, it is first converted to malate and aspartate. Malate and 
aspartate are transported across the membrane of the mitochondrion and converted back 
to OAA once in the cytosol. These reactions require NADH within the mitochondria and 
NAD+ in the cytosol (Exton, 1972; Berg et al., 2002). Cytosolic OAA can then serve as a 
substrate for PCK1 conversion to PEP. Conversion of OAA to PEP by PCK2 occurs in 
the mitochondria (Berg et al., 2002). Deficiency of PCK1, even with maintained PCK2 
activity, results in hepatic steatosis, hypoglycemia, and death before early childhood 
(Vidnes and Sovik, 1976), illustrating the central metabolic role of the enzyme.  
 Subsequent reactions of gluconeogenesis require enzymes to overcome the kinetic 
barriers of the glycolysis pathway. The actions of phophofructokinase in glycolysis are 
circumvented by conversion of fructose 1,6-bisphosphate to fructose 6-phosphate by 
fructose 1,6-bisphosphatase. Finally, glucose-6-phosphatase catalyzes the conversion of 
glucose 6-phosphate to glucose, allowing for release of glucose to the blood stream (Berg 
et al., 2002). The rate-limiting enzymes for gluconeogenesis are therefore PC, PCK, 
fructose 1,6-bisphosphatase, and glucose-6-phosphatase. It is important to note that 
glucose-6-phosphatase is only expressed in liver and kidney, and not muscle or adipose 
tissue. This prevents substrate release from these glucose-utilizing, non-gluconeogenic 
tissues (Exton, 1972). Furthermore, ruminant liver expresses hexokinase, rather than 
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glucokinase. Hexokinase has a comparatively lower Km for glucose (Raggi et al., 1963; 
Hayirli, 2006). This allows for the important distinction that glucose is not extracted, but 
released from ruminant liver.  
 
Gluconeogenesis in Ruminants  
 Nonruminants are supplied during the postprandial state through intestinal 
absorption with large quantities of glucose. The main obstacle to overcome in 
nonruminant glucose metabolism is maintaining glycogen stores after absorption, and 
mobilization from these stores (Woerle et al., 2003). Gluconeogenesis from de novo 
sources is only necessitated during fasting or under periods of increased glucose demand, 
such as exercise. Microbial fermentation of fiber carbohydrates in the forestomach, or 
rumen, of ruminant animals allows for the utilization of feedstuffs indigestible by 
nonruminants. In functional ruminants, dietary carbohydrates are fermented to volatile 
fatty acids (VFA), including propionate, leaving minimal amounts of exogenous glucose 
available (Ballard et al., 1969; Reynolds et al., 1988). Very little glucose is therefore 
presented for intestinal absorption, and ruminant glucose needs must be met through de 
novo gluconeogenesis. In ruminants, propionate serves as the principal substrate for 
gluconeogenesis (Reynolds et al., 2003). Furthermore, intestinal absorption of any 
glucose present is extremely limited in ruminants (Mills et al., 1999). Therefore, by 
necessity, over 90% of glucose requirements in ruminant animals is met through de novo 
gluconeogenesis (Aschenbach et al., 2010).  
 The requirement for do novo gluconeogenesis is drastically augmented with the 
onset of milk production during lactation in dairy cows. Lactose, the major milk osmole, 
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depends on the availability of glucose as its major precursor during milk synthesis (Barry, 
1964; Smith, 1971). Between 60-85% of total glucose requirements in lactating 
ruminants can be attributed to lactose synthesis in mammary gland (Annison and Linzell, 
1964). Splanchnic measurements have determined that the difference in glucose uptake 
by mammary gland in lactating ruminants cannot be accounted for simply by increases in 
glucose absorption across the portal-drained viscera (Doepel et al., 2009). Additionally, 
studies utilizing isotope tracers have found that the rate of de novo glucose synthesis and 




 Gluconeogenic amino acids, glycerol, lactate, and propionate serve as the 
precursors for de novo gluconeogenesis. Ruminant gluconeogenesis is, in stark contrast to 
gluconeogenesis in nonruminants, highest during the postprandial period when both the 
production, and absorption, of propionate are increased (Reynolds et al., 2003). 
Propionate serves as the primary precursor for do novo gluconeogenesis during the 
postprandial state when the contribution from propionate is up to 60-80% (Annison and 
Bryden, 1999; Aschenbach et al., 2010). Approximately 95% of propionate that is 
absorbed from ruminal fermentation is subsequently converted to glucose, making this 
process exceptionally efficient in ruminant animals (Steinhour and Bauman, 1988). In 
contrast, de novo gluconeogenesis from propionate is dramatically decreased during 
fasting, or during periods of imposed feed restriction (Lomax and Baird, 1983). After a 
24 h fast, utilization of propionate by liver was decreased 80% and net glucose output 
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decreased by 45% (Lomax and Baird, 1983). This lack of gluconeogenic precursors is 
emphasized during the postpartum period when drastic glucose demands, accompanying 
lactogenesis and lactose synthesis, are not met by feed intake (Bell, 1995). In turn, 
gluconeogenesis from other precursors must increase to meet metabolic demands. 
Contributions to de novo gluconeogenesis from lactate, gluconeogenic amino acids, and 
glycerol range between 16-26%, 11-16%, and 0.5-3%, respectively (Aschenbach et al., 
2010). Mobilization of body fat reserves during periods of severe negative energy 
balance, including the periparturient period in dairy cows, increase the availability of 
fatty acids for metabolism in liver. Triglyceride degradation in liver supplies glycerol for 
de novo gluconeogenesis. Approximately 15-20% of glucose requirements during these 
periods can be met through mobilization of adipose tissue reserves (Bell, 1995).  
 
Fatty Acid Synthesis  
 Synthesis of fatty acids, de novo, requires a carbon source to serve as the glycerol 
backbone. Cytosolic citrate lyase (EC 4.1.3.8) catalyzes the cleavage of citrate, in the 
presence of Coenzyme A and ATP, to OAA and acetyl-CoA. Fatty acid biosynthesis 
utilizes this citrate cleavage as the initial step in fatty acid generation from acetyl-CoA 
and malonyl-CoA precursors (Ballard and Hanson, 1967). Citrate formation from OAA is 
dependent upon the pool of OAA generated by PC. For utilization in other biochemical 
reactions, regenerated cytosolic OAA from the citrate lyase reaction would first need to 
be converted to malate by malate dehydrogenase (EC 1.1.1.40), and then to pyruvate to 
permit translocation into the mitochondria.  
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In contrast, adipose tissue is the primary site of fatty acid synthesis in ruminants 
(Ingle et al., 1972), where acetate utilization, compared to glucose substrate utilization, is 
increased ten times over that in liver, adipose, and mammary gland of ruminants, 
compared to nonruminants (Hanson and Ballard, 1967). Dramatically decreased 
abundance of citrate lyase in ruminant liver prevents the citrate cleavage reaction to OAA 
and acetyl-CoA (Hanson and Ballard, 1967; Ingle et al., 1972). Ruminant fatty acid 
biosynthesis is supported, in large part, by acetyl-CoA synthase (EC 6.2.1.1), which 
catalyzes the formation of acetate to acetyl-CoA (Hanson and Ballard, 1967). A 
discrepancy currently exists over the activity of citrate lyase in dairy cows, particularly 
during the peripartum period, with some findings to indicate that citrate lyase activity 
increases postpartum in control cows, but remains lower in dairy cows with fatty liver 
(Murondoti et al., 2004), with a similar study finding increased citrate lyase levels at 4 
wk postpartum, compared to 3 wk prepartum, but a decreased level at 13 wk postpartum 
(Graber et al., 2010). In opposition to these findings, no differences were seen in citrate 
lyase in dairy cows with high or low BHBA levels during the peripartum period (van 
Dorland et al., 2009) or during feed restriction postpartum (Gross et al., 2013). Acetyl-
CoA has also been shown to inhibit citrate lyase, further depressing enzyme activity 






REGULATION OF PYRUVATE CARBOXYLASE 
 
Pyruvate Carboxylase Gene Promoters 
 Short-term regulation of PC is largely influenced by availability of the allosteric 
activator, acetyl-CoA, as discussed above. Increases in acetyl-CoA supply from the 
metabolism of mobilized fatty acids can enhance OAA production by PC and the 
cataplerotic supply of carbons to gluconeogenesis. Long-term regulation of PC occurs 
through transcriptional regulation of PC gene promoters by both nutritional and 
physiological cues. Regulation of PC mRNA expression in mammals is complex. Studies 
in rat and mouse models (Jitrapakdee et al., 1996; Jitrapakdee et al., 1997; Jitrapakdee et 
al., 2001), and on human PC regulation (Carbone et al., 1998; Thonpho et al., 2013) have 
revealed regulation by multiple promoters. Two alternative promoters, the proximal (P1) 
and distal (P2), have been identified in rat (Jitrapakdee et al., 1996). Through alternative 
splicing, these promoters yield five different mRNA variants, differing only in their 5’ 
untranslated regions (UTR), produced from different 5’ UTR exons. Illustrating an added 
level of genomic complexity, bovine PC gene contains three unique promoter regions 
(P3, P2, P1 from 5’ to 3’) which yield six unique 5’ UTR variants (Hazelton et al., 
2008b). Similar to human and rat, tissue-specific PC mRNA expression is seen in bovine 
where 5’ UTR A, B, C, and F (arising from promoter 1) are specific to glucogenic and 
lipogenic tissues and 5’ UTR D and E (arising from promoter 3 and promoter 2, 
respectively) are expressed in several different tissues (Agca et al., 2004; Hazelton et al., 
2008b). In rat, 5’UTR products of P1 are expressed in gluconeogenic and lipogenic 
tissues, while 5’UTR products of P2 are more ubiquitous (Jitrapakdee et al., 1996; 
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Jitrapakdee et al., 1997). Expression of tissue-specific variants is likely due to the 
presence of tissue-specific transcription factors that may interact with specific response 
elements of the unique promoters (Jitrapakdee et al., 1999).  
 Different tissue-specific PC promoters also exhibit different translational 
efficiencies. In rats, transcripts from 5’ UTR C or E exhibit similar translational 
efficiencies, which are both higher than translational efficiency from 5’ UTR D 
(Jitrapakdee et al., 1998). Transcript D was shown to potentially develop a secondary 
structure blocking access for translation (Jitrapakdee et al., 1998). Similarly, in bovine, 
translation efficiencies of PC mRNA variants A, B, D, and F did not differ (Hazelton et 
al., 2008a). Translation efficiency from bovine PC 5’ UTR D was greater than synthesis 
from PC 5’ UTR C or E for bovine PC (Hazelton et al., 2008a). The pattern of PC 5’ 
UTR variants expressed may therefore influence the total rate of PC enzyme synthesis. 
Response of species 5’ UTR variants to physiological cues is then of specific interest to 
determine the complete pattern of transcriptional regulation of PC. The products of 
bovine PC promoter 1, UTR variants A, B, C, and F, exhibit increased expression of 4-
fold in samples from feed restricted cows and 6-fold during parturition (White et al., 
2011a).  
  
Nutritional Control of Pyruvate Carboxylase 
 The activity of hepatic PC in rats after a period of starvation dramatically 
increases, up to three-fold, compared to activity in control rats (Wimhurst and 
Manchester, 1970). This parallel between increased PC activity and decreased caloric 
intake is seen in several other species, including bovine (Ballard et al., 1968), guinea pig 
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(Söling et al., 1970), and sheep (Taylor et al., 1971; Lemons et al., 1986). Increased 
expression of PC mRNA during feed restriction has been reported in mid-lactation dairy 
cows (Velez and Donkin, 2005). This increase in PC was concurrent with an increase, of 
nearly four times control levels, of lactate converted to glucose (Velez and Donkin, 
2005). During this change in the capacity for gluconeogenesis from lactate, plasma 
NEFA levels were simultaneously increased in the feed restriction group, compared to 
control (Velez and Donkin, 2005). Potential regulation of PC gene expression by fatty 
acids is discussed in the following section.  
Increased plasma NEFA levels during a period of caloric deprivation result from 
the mobilization of adipose tissue reserves. This homeorhetic response to the increased 
nutritional demands due to the onset of lactation and demands of the gravid fetus is 
heightened during the transition period in dairy cows, the time from 3 wk prior to 
parturition until 3 wk after parturition. During this period of dramatic increase in energy 
requirement, PC mRNA levels also increase. Hepatic PC mRNA levels are elevated at 
calving, and 7 d postpartum (Greenfield et al., 2000). Other gluconeogenic enzymes, 
including PCK, do not show this same pattern. Increases in PCK mRNA expression do 
not occur until 28 d postpartum (Greenfield et al., 2000; Agca et al 2002).  
 Dietary fat has been shown to alter whole body metabolism in both rats and mice 
(Kraegen et al., 1991; Bizeau et al., 2001; Hagopian et al., 2004). A high saturated fat 
diet promotes insulin resistance and obesity with concurrent increases in serum 
triglyceride levels in rodents (Kraegen et al., 1991). A study in rats comparing the effects 
of high fat, sucrose, or starch in the diet found that increased gluconeogenesis observed in 
the high fat and sucrose diets was due to increased flux through PC (Bizeau et al., 2001). 
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In dairy cows, diets fed prepartum have been shown to influence the concentration and 
profile of circulating fatty acid postpartum (Rukkwamsuk et al., 2000). Taken together 
with the concurrent increase in PC postpartum (Greenfield et al., 2000), the role for 
potential influence of circulating fatty acids on PC flux becomes of particular interest.  
 
Transcriptional regulation of Pyruvate Carboxylase by long-chain fatty acids 
 Fatty acids have been shown to alter signal transduction cascades, regulate 
activity of G-protein-linked membrane receptors, and, along with their acyl-CoA 
derivatives, can bind to several transcription factors, including peroxisome proliferator-
activated receptors (PPAR), sterol regulatory element binding protein (SREBP), 
carbohydrate-responsive element-binding protein (ChREBP), liver X receptor (LXR), 
farnesoid X receptor (FXR), toll-like receptor 4 (TLR4), hepatic nuclear factor-4 α 
(HNF-4α), and nuclear factor (NF) κB, to regulate gene transcription. Circulating long 
chain nonesterified fatty acids (NEFA) are transported through blood bound to albumin. 
While blood fatty acids also include esterified fatty acids in triglycerides, lipoproteins, 
and chylomicrons, these fatty acids, arising from dietary sources, are largely unavailable 
to liver as adult liver lacks lipoprotein lipase required to free esterified fatty acids 
(Semenkovich et al., 1989; Goldberg et al., 2009). Furthermore, mature ruminant liver 
contains essentially no lipoprotein lipase or hepatic triglyceride lipase (Cordle et al., 
1983; Liesman et al., 1984) to allow for lipoprotein utilization. This review will therefore 
focus solely on NEFA uptake and utilization.  
For cellular uptake, over 90% of cellular long chain fatty acid movement into 
cells is through protein-mediated uptake (Kazantzis and Stahl, 2012). Specifically, 
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plasma membrane fatty acid-binding protein (FABP), fatty acid translocase (CD36), and 
fatty acid transport proteins (FATP), are responsible for the majority of cellular fatty acid 
uptake. In addition to their role in cellular fatty acid uptake, it remains unclear if FATP 
play a direct role fatty acyl-CoA synthesis or transport within the cell (Jump et al., 2005; 
Kazantzis and Stahl, 2012). Inside the cell, fatty acids can serve as signaling molecules 
through their influence on cellular receptor systems, including steroid hormones, retinoic 
acid, and other hydrophobic molecules (Chawla et al., 2001). Research in several species 
has illustrated the role of fatty acids in regulation of PC (Jitrapakdee et al., 2008). 
Research on the direct action of fatty acids to control gene expression, especially in 
bovine has, thus far, been limited. Responsiveness of other gluconeogenic genes to fatty 
acids has been studied in several species, and may provide insight to regulation of PC by 
fatty acids and associated intracellular systems in bovine.  
 
Regulation by PPAR 
Peroxisome proliferator-activated receptors are nuclear hormone receptors which 
function as ligand-dependent transcription receptors, with ligands including small 
lipophilic molecules such as fatty acids, peroxisome proliferators, antidiabetic, and 
hypolipidemic drugs (Schoonjans et al., 1996). Ligand binding to PPAR elicits 
heterodimerization of PPAR with retionoid X receptor (RXR) and subsequent binding to 
response elements and recruitment of coactivator proteins. The predominant form in liver 
is PPARα, which had been implicated in a central role of lipid metabolism and fatty acid 
oxidation (Lee et al., 1995). The PPARα subtype is also expressed in brown adipose 
tissue, as well as cardiac and skeletal muscle (Georgiadi and Kersten, 2010). Subtype 
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PPARγ is highly expressed in adipocytes and macrophages where it promotes 
differentiation of preadipocytes and lipid storage, while subtype PPARδ exhibits a more 
ubiquitous expression (Sugden et al., 2010).  
Long chain fatty acids, and in particular polyunsaturated fatty acids (PUFA), 
preferentially bind to all PPAR subtypes (Krey et al., 1997). The role for PPARα in 
mediating hepatic gene expression through unsaturated fatty acids was confirmed from 
gene expression profiles in PPARα null mice provided with synthetic dietary triglycerides 
comprised of only one fatty acid (Sanderson et al., 2008). Additionally, PPARα null mice 
in the fed state exhibit reduced lactate production and gluconeogenesis, while fasted 
PPARα null mice are unable to switch to fatty acid oxidation (Xu et al., 2002). Although 
PC mRNA expression or enzyme activity was not measured in the PPARα null mice, the 
role for PPARα in gluconeogenesis from lactate is clear and may directly relate to PC 
activity and potential regulation by fatty acids.  
Interestingly, differences are found between the ability of circulating fatty acids, 
arising from mobilization of adipose tissue, compared to fatty acids of dietary origin, to 
activate PPARα in liver (Chakravarthy et al., 2005; Sanderson et al., 2009). This inability 
of circulating fatty acids to activate PPARα may be due to differences in intracellular 
pools of fatty acids as only fatty acids of dietary origin acted through PPARα to influence 
glucose or fatty acid metabolism in liver-specific fatty acid synthase knockout mice 
(Chakravarthy et al., 2005). Differences are also seen in PPARα activation in response to 
physiological cues during fasting compared to response to pharmacological agonists 
where PPARδ is responsive to circulating fatty acids, but the same is not true for PPARα 
in mouse liver (Sanderson et al., 2009). This difference in response to fatty acids of 
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dietary or adipose origin may be of particular interest in the periparturient dairy cow 
when feed intake electively decreases and adipose tissue mobilization increases. 
However, implications from these studies must carefully be considered because of the 
lack of lipoprotein lipase or hepatic triglyceride lipase in ruminant liver (Cordle et al., 
1983; Liesman et al., 1984) which limits utilization, by liver, of fatty acids from 
chylomicrons of dietary origin. Studies evaluating the response of different PPAR 
isoforms to fatty acids of either dietary or adipose origin in ruminants are lacking, but 
lipoprotein lipase is shown to be increased by PPARα ligands in human macrophages (Li 
et al., 2002).  
Direct regulation of genes involved in fatty acid metabolism through PPARα has 
been examined in both rodent and bovine. Research in rodent models had indicated that 
the proximal PC promoter is responsive to PPARα activation (Jitrapakdee et al., 2008). 
Increased PC expression is seen in isolations of pancreatic islets from rats after treatment 
with either long chain fatty acids or synthetic PPARα agonist, fibrate, concurrent with an 
increase in PPARα expression (Yoshikawa et al., 2001). In bovine, responsiveness of 
carnitine palmitoyltransferase (CPT) I activity is seen in Madin-Darby bovine kidney 
(MDBK) cells after exposure to the PPARα agonist Wy-14643 (Bionaz et al., 2008a), 
while direct activation of PPARα by long chain fatty acid is seen in the same cell model 
(Thering et al., 2009). Specific regulation of bovine PC promoter 1 is seen with activation 
by PPARα and a decrease in promoter activity after exposure to saturated fatty acids 
(White et al., 2011c). Finally, both PPARα and PPARδ have been shown to increase lipid 
oxidation in heart, intestine, kidney, and liver (Sugden et al., 2010; Jump et al., 2013). In 
neonatal bovine hepatocyte isolations, exposure to a PPARα agonist increased oxidation 
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of C16:0 to CO2, compared to control (Litherland et al., 2010). The importance of fatty 
acid oxidation in relation to the role of PC is discussed below. Together, these data lend 
support to the hypothesis than fatty acid influence on PC mRNA expression is mediated 
through PPARα.  
 
Regulation by SREBP 
Sterol regulatory element binding proteins are members of the basic helix-loop-
helix leucine zipper family of transcription factors and exhibit three isoforms, SREBP-1a, 
SREBP-1c and SREBP-2, from two separate genes. The isoforms are expressed in a 
tissue-specific manner and elicit their effects on different target genes with SREBP-1c 
activating genes for de novo lipogenesis and SREBP-2 activating genes involved in the 
synthesis and uptake of cholesterol (Georgiadi and Kersten, 2010). Synthesized as 
membrane-bound precursors in the endoplasmic reticulum, activation of SREBP requires 
cleavage by cholesterol-sensing proteins, known as SREBP cleavage activating proteins 
(SCAP). Cleavage and release of SREBP allows for nuclear translocation and binding to 
response elements (Hua et al., 1995). Serving, in effect, as cholesterol-sensing proteins, 
SCAP promote cleavage and SREBP nuclear translocation when cholesterol levels are 
low. Increased cellular cholesterol concentrations leave the SREBP-SCAP complex 
sequestered by endoplasmic reticulum (ER) membrane proteins (Hua et al., 1995). 
All SREBP isoforms are inhibited by PUFA, as these fatty acids act to both 
decrease SREBP mRNA levels, and prevent the cleavage and processing required for 
SREBP maturation (Xu et al., 1999). Inhibition of SREBP through PUFA has recently 
been attributed to the inhibition of Ubxd8, a membrane-bound protein responsible for 
24 
degrading the proteins anchoring the SREBP-SCAP complex to the ER (Lee et al., 2010). 
Inhibition of Ubxd8 and the related anchoring protein leaves the SREBP-SCAP 
inactivated and stranded in the ER.  
The predominant isoform in liver, SREBP-1c, plays a direct role in the regulation 
of lipogenesis and is responsible for the activation of fatty acid and triglyceride synthesis-
related gene transcription (Shimano, 2009). Expression of SREBP-1c is increased during 
periods of elevated glucose concentrations and during over-nutrition, and is upregulated 
by insulin and agonists of LXR. Long-term elevation of SREBP-1c can induce insulin 
resistance and fatty liver (Horton et al., 1998; Nakamura et al., 2004). In opposition, 
SREBP-1c is downregulated by PUFA (Shimano, 2009). Recent research has established 
a relationship between elevated C18:0 levels in Type II diabetes patients with 
hyperlipidemia from increased fatty acid synthesis due to signaling through SREBP-1c 
(Chu et al., 2013). Any potential relationship between SREBP signaling and PC 
expression has not been examined in ruminants or nonruminants.  
 
Regulation by LXR and Relationship to SREBP 
 Liver X receptors belong to the nuclear receptor superfamily, are responsive to 
sterols, and are relevant to several metabolic systems, including growth and development, 
reproduction, overall metabolism, and, specifically, Type II diabetes (Ding et al., 2014). 
The LXR are activated by oxysterols, derivatives of cholesterol, and activate genes for 
cholesterol and bile excretion (Nakamura et al., 2014). Liver X receptor null mice exhibit 
aberrant cholesterol accumulation and liver metabolism (Peet et al., 1998). Effects of 
LXR on other metabolic aspects occur through interactions with either SREBP-1c or 
25 
PPARα. Two functional LXR response elements are found in the promoter region of the 
SREBP-1c gene (Repa et al., 2000). Through activation of SREBP-1c, LXR also induces 
genes for de novo lipogenesis (Nakamura et al., 2014). Evaluation of cross-talk between 
PPARα and LXR demonstrated that overexpression of PPARα in human embryonic 
kidney cells inhibited LXR-induced SREBP-1c activity (Yoshikawa et al., 2003). 
Confirmed through gel shift assays and incubation with PPARα agonists, the activation of 
PPARα is likely competitively reducing formation of a LXR-RXR heterodimer to reduce 
signaling through the LXR-SREBP-1c pathway (Yoshikawa et al., 2003).  
 
Regulation by TLR4 
Toll-like receptors are highly conserved proteins intricately involved in the innate 
immune response which recognize pathogen-associated molecular patterns and mediate 
cytokine responses (Galli and Calder, 2009). Effects of fatty acids on inflammatory 
response have been extensively studied and data largely support a proinflammatory role 
of saturated fatty acids and an anti-inflammatory role of n-3 PUFA (Galli and Calder, 
2009). While much of the influence from fatty acid metabolism is likely from 
metabolites, including prostaglandins, leukotrienes, and diacylglycerols, a direct role also 
exists for fatty acids in both pro- and anti-inflammatory pathways. The TLR4 subtype is 
of particular interest because of the activation of the receptor by both lipopolysaccharides 
and fatty acids. In both adipocytes and monocytes, saturated C16:0 and C18:0 serve as 
direct ligands to stimulate TLR4 signaling and elicit downstream NFκB activation and 
proinflammatory cytokine release (Kopp et al., 2009; Schaeffler et al., 2009).  
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Taken together, previous research strongly suggests a role of both unsaturated and 
saturated fatty acids, through their influence on PPARα and SREBP-1c, respectively, in 
regulating hepatic gene expression. Presently, the role of these lipid classes as regulators 
of hepatic gene expression in bovine, and transition dairy cows in particular, is unknown. 
Data for PC regulation in nonruminants and emerging data for ruminants suggests 
dominant regulation by unsaturated fatty acid on potential PPARα response elements of 
PC. A role of LXR as a cotranscription factor is also plausible when considering the 
established role of cross-talk between PPARα, LXR, and SREBP-1c. Research is lacking 




FATTY ACID METABOLISM AND β-OXIDATION 
 
 Long-chain fatty acids are mobilized from adipose tissue during increased energy 
requirements, which exceed energy supply, in the form of NEFA that bind to serum 
albumin and are transported in blood (Dole, 1956; Gordon and Cherkes, 1956). In dairy 
cows, circulating NEFA taken up by liver in proportion to their concentration in blood 
(Emery et al., 1992) and are subject to one of several metabolic fates, including complete 
oxidation to CO2 or partial oxidation to yield ketone bodies (reviewed in full below). 
Because PC is allosterically regulated by acetyl-CoA, and because the anaplerotic 
potential of PC depends on acetyl-CoA condensing with OAA to enter the TCA cycle, 
supply of acetyl-CoA from fatty acid β-oxidation is of particular interest.  
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Fatty acid β-oxidation pathway 
 The catabolic breakdown of fatty acids in mitochondria yields acetyl-CoA, which 
can enter the TCA cycle, and NADH and FADH2, which are used in the electron 
transport chain (Berg et al., 2002). In healthy individuals, decreases in circulating glucose 
and insulin levels during fasting permit the activation of adipose tissue hormone-sensitive 
lipase (HSL) by opposing endocrine signals to increase NEFA mobilization (Bennett, 
2010). Activation of HSL in adipose tissue occurs through the protein kinase A cascade 
promoting HSL to translocate and hydrolyze triglycerides from lipid droplets. In contrast 
to nonruminants, adipose triglyceride lipase is decreased during the periparturient period 
in dairy cows (Koltes and Spurlock, 2011). Fatty acids are oxidized in mitochondria but 
must first be activated, at the outer mitochondrial membrane, by acyl-CoA synthetase / 
fatty acid thiokinase to long chain fatty acyl-CoA. Activated long chain fatty acyl-CoA 
are then conjugated to carnitine for transport across the mitochondrial membrane, 
facilitated by the outer-membrane-bound CPT I (Berg et al., 2002). Four enzyme-
catalyzed reactions are then required for fatty acid β-oxidation: dehydrogenation by acyl-
CoA dehydrogenase, hydration by enoyl-CoA hydratase, dehydrogenation by 3-L-
hydroxyacyl-CoA dehydrogenase, and cleavage by thiolase. The resulting fatty acyl-CoA 
is shortened by two carbons while acetyl-CoA, NADH and FADH2 are generated (Berg et 
al., 2002). Resulting acetyl-CoA can then continue to complete oxidation through the 
TCA cycle (pathway discussed above) only if fat and carbohydrate metabolism are 
balanced. If OAA is unavailable for condensation with acetyl-CoA, acetyl-CoA is then 




Figure 1.2. Fatty acid β-oxidation; substrates, products, and associated enzymes. 
Activated fatty acyl-CoA are conjugated to carnitine for transport across the 
mitochondrial membrane, facilitated by carnitine palmitoyltransferase (CPT) I, prior to β-
oxidation. Acetyl-CoA resulting from the final cleavage step can be oxidized through the 






































Role of fatty acid β-oxidation in liver and kidney tissue 
Complete oxidation of fatty acids to CO2 necessitates a balance between 
mitochondrial β-oxidation and peroxisomal β-oxidation. Peroxisomal β-oxidation is 
utilized for breakdown of fatty acids longer than 20 carbons before further oxidation in 
the mitochondria proceeds (Osmundsen et al., 1991). While mitochondrial β-oxidation is, 
in large part, dependent upon CPT I activity (McGarry and Brown, 1997), limitations in 
CPT I activity have not been linked to propensity for metabolic disorders in periparturient 
dairy cows (Dann and Drackley, 2005).  
Kidney and liver are the only tissues in which both mitochondrial β-oxidation and 
peroxisomal β-oxidation of fatty acids can occur (Osmundsen et al., 1991; Zaar, 1992). 
Complete oxidation of long chain fatty acids, specifically C16:0, to CO2 by extrahepatic 
tissues was first demonstrated in vitro in murine kidney slices (Weinhouse et al., 1950). 
Oxidation of C16:0 to CO2 in kidney slices or homogenates was equal to or greater than 
oxidation of C16:0 to CO2 in liver slices or homogenates (Weinhouse et al., 1950). Early 
liver explant incubations in bovine illustrated that oxidation of C16:0 is stimulated by 
carnitine and inhibited by propionate (Jesse et al., 1986). In liver of dairy cows, 
peroxisomal β-oxidation contributes 50% of first cycle total C16:0 β-oxidation (Grum et 
al., 1994). Importance of the capacity for oxidation in dairy cows is emphasized around 
parturition and was previously shown to increase in the oxidation of C16:0 in liver tissue 
slices (Grum et al., 1996). In a rodent model, regulation of fatty acid oxidation is 
demonstrated after dietary fat containing high amounts of C18:3n-3 cis increase both 
mitochondrial and peroxisomal fatty acid β-oxidation in rat liver (Ide et al., 1996). 
Experiments performed in bovine hepatocytes examined the influence of fatty acids after 
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48 h exposure and found a decrease in fatty acid esterification to triglycerides when 
C18:3n-3 cis was included in treatment media (Mashek and Grummer, 2003). An 
increase in gluconeogenesis is also seen after exposure to C18:3n-3 cis in hepatocytes 
(Mashek and Grummer, 2003). The negative effects of overfeeding during the dry period 
on enzymes related to NEFA oxidation in liver have also been established (Murondoti et 
al., 2004), while lower rates of C16:0 oxidation to CO2 are observed after overfeeding 
during the far-off dry period with a concurrent increase in the esterification of 
triglycerides (Litherland et al., 2011). These studies effectively established a method for 
analysis of fatty acid substrate metabolism, and illustrated influences of diet and, 
specifically, fatty acids, but did not measure PC mRNA expression or enzyme activity, 
and the exact role of PC remains uncertain.  
Fatty acid β-oxidation also occurs in proximal kidney tubules of the renal cortex 
and is increased during diabetes (Guder et al., 1986). Potentially strengthening the link 
between fatty acid β-oxidation and PC activity, fatty acids that are increased in 
circulating concentrations during diabetes are found to induce expression of several fatty 
acid β-oxidation enzymes and promote the utilization of fatty acids (Ouali et al., 1998). 
Furthermore, all PPAR isoforms are detected in kidney cortex (Wang, 2010). As bovine 
PC promoter 1 activated by PPARα agonist (White et al., 2011c), the relevance of 





ROLE OF PYRUVATE CARBOXYLASE IN ABERRANT METABOLISM 
 
Evolutionary conservation and biological importance 
 The PC gene has been highly conserved through evolution and is found in both 
bacteria and eukaryotic cells. Well characterized in Saccharomyces cerevisiae, this yeast 
contains two functional PC gene copies; PYC1 and PYC2, with both isozymes being 
located in the cytoplasm (Walker et al., 1991). This is in contrast to cellular localization 
of PC in the mitochondrial matrix, near the mitochondrial inner membrane, in higher 
eukaryotes (Rhode et al., 1991). A single PC gene is found in rats, humans, and cows 
with high similarity; containing 19 coding exon regions and 18 introns (Jitrapakdee and 
Wallace, 1999; Hazelton et al., 2008b). Mammalian control of PC expression is 
intricately regulated by distinct promoters, discussed in full detail in previous sections. 
The pivotal role of PC in several physiological states will be the focus of the following 
section. The biological importance of the enzymes is perhaps most easily illustrated by a 
brief review of studies of compromised PC function.  
 Generation of PC-deficient mutants in S. cerevisiae result in altered phenotypes, 
while defects in either the PC1 or PC2 genes led to growth failure in yeast on glucose 
media (Walker et al., 1991; Brewster et al., 1994). Deficiency of PC in humans is an 
autosomal, recessive trait, which manifests as one of three, nearly distinct, phenotypes 
(Gray et al., 2014). Type A PC deficiency, found in North American populations, is 
characterized by decreased, though not abolished, PC activity, episodic lactic acidosis, 
elevated alanine and proline levels, hypoglycemia, and developmental delays (Robinson, 
2006). Decreases in both gluconeogenesis and activity of the TCA cycle are responsible 
32 
for decreased OAA and glucose, and increased alanine, lactate, and pyruvate in these PC-
deficient individuals (Jitrapakdee and Wallace, 1999). Life expectancy of Type A-
deficiency patients is usually several years (Gray et al., 2014). In contrast, Type B PC 
deficiency, historically reported in French populations, is characterized by near absence 
of PC protein or enzyme activity. Severe lactic acidosis and neurological deficits occur, 
and lifespan in these patients is usually only several months (Robinson, 2006). Type C 
PC deficiency is, in comparison, a very mild form of the disease, lacking neurological 
complications and exhibiting limited and infrequent lactic acidosis (Gray et al., 2014). 
Point mutations leading to altered protein stability or lower enzyme activity have been 
identified in patients with Type A PC deficiency, and PC activity among these patients is 
around 50% (Wexler et al., 1998). The genotype for Type B deficiency has not yet been 
identified. The severe implications of PC deficiency emphasize the central role for the 
enzyme in numerous metabolic pathways.  
 
Obesity and Type II Diabetes Mellitus 
 Type II diabetes mellitus, or noninsulin-dependent diabetes mellitus, is a 
metabolic disorder arising from both genetic and lifestyle factors characterized by 
hyperglycemia, insulin resistance, and insulin deficiency. Increases in all gluconeogenic 
genes; PC, PCK, fructose-1,6-bisphosphatase, and glucose-6-phosphatase have been 
reported during diabetes mellitus (Filsell et al., 1969; Wimhurst and Manchester, 1970; 
Weinberg and Utter, 1980). Insulin has been previously shown to decrease this elevated 
PC expression, by two-fold, in diabetic rats (Weinberg and Utter, 1980). Genetically 
obese rats also exhibit dramatic increases in PC expression, which has been specifically 
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attributed to a response by the distal PC promoter in pancreatic β-cells (Jitrapakdee et al., 
1998). Increased gluconeogenesis in diabetes was later specifically attributed to an 
increase in flux through PC in its cataplerotic role in both mice and rats (Salto et al., 
1996).  
 In a genetically inherited Type II diabetic rat model, elevated glucose levels due 
to insulin resistance results in a “glucotoxicity loop” and concomitant decrease in PC 
activity (MacDonald et al., 1996a,b; Poitout et al., 2002). The ensuing “lipotoxicity loop” 
only serves to increase insulin resistance, decrease PC activity, and decrease pancreatic β-
cell function (Poitout et al., 2002). Finally, identification of a single nucleotide 
polymorphism in the PC gene has been identified and linked to the acute insulin response 
phenotype, an independent predictor of Type II diabetes mellitus (Palmer et al., 2006).  
 
Ketosis and Fatty liver 
Hepatic steatosis, or the accumulation of excessive lipid in liver, has been linked 
to the development of nonalcoholic fatty liver disease (Malhi and Gores, 2008). 
Accumulation of these liver lipids occurs from an imbalance between the rates of 
synthesis and disposal. How liver responds to the excess lipid load during the increased 
influx determines potential susceptibility to development of hepatic steatosis.  
The 6 wk period surrounding parturition in dairy cows is aptly referred to as the 
transition period. As this moniker implies, drastic metabolic changes are occurring as a 
homeorhetic response to increased nutrient needs of the fetus, and the onset of 
lactogenesis. During this period of extreme negative energy balance, adipose tissue 
reserves are mobilized, releasing NEFA into the bloodstream which are transported to 
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liver for mitochondrial metabolism (Baird et al., 1968; LeBlanc, 2010). Concurrent with 
increased circulating NEFA from adipose tissue triglyceride lipolysis, the rate of blood 
flow increases during the periparturient period in dairy cows (Lomax and Baird, 1983). 
Circulating NEFA in dairy cows are taken up by liver proportional to their concentration 
in blood (Emery et al., 1992) and are subject to one of four possible fates: complete 
oxidation through the tricarboxylic acid (TCA) cycle yielding ATP and CO2, partial 
oxidation yielding ketone bodies, esterification for storage in liver as triglycerides, or 
transport from the liver as very low density lipoprotein (VLDL) for use by extrahepatic 
tissues (reviewed by Grummer, 1993; Drackley et al., 2001; Bobe et al., 2004; van 
Knegsel et al., 2005). With the cost of hepatic steatosis to the United States dairy industry 
estimated at US$60 million annually and the prevalence of hepatic steatosis in early 
lactation dairy cows at over 50% (Bobe et al., 2004), potential strategies to mitigate the 
severity of the disease and the cost to dairy producers are necessary.  
Dairy cows exhibit an inherently low capacity for export of VLDL from liver, and 
display an upper limit of extrahepatic tissues to utilize ketone bodies (Kleppe et al., 1988; 
Armentano et al., 1991; Emmison et al., 1991). This is, in part, due to the fact that 
ruminants express limited concentrations of the proteins necessary for VLDL packaging, 
including apolipoprotein B and apolipoprotein A-I (Grummer, 1993, Bobe et al., 2004). 
This puts a dairy cow at an even greater risk for developing ketosis or fatty liver. 
Decreases in feed intake during the transition period may result in decreased carbon 
supply from propionate and decreased availability of OAA to serve as a substrate (van 
Knegsel et al., 2005). Increased production of acetyl-CoA, resulting from fatty acid β-
oxidation, during a period of increased energy demand could surpass the capacity of the 
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TCA cycle for complete oxidation. If OAA and acetyl-CoA are not present in an equal 
ratio to serve as TCA cycle substrates, other metabolic fates of acetyl-CoA will 
predominate. Increased rates of ketogenesis to acetate and acetoacetate from acetyl-CoA, 
along with increased esterification to storage triglycerides (Grummer 1993, Drackley et 
al., 2001, van Knegsel et al., 2005) would simply exacerbate the delicate metabolic 
situation of the transition cow. While the decrease in feed intake is usually greater in 
obese cows compared to healthy individuals (Stockdale, 2001), NEFA mobilization in 
obese dairy cows is also more severe (McNamara, 2000). Because liver lipids can 
accumulate very rapidly and fatty liver can develop in as little as 96 h in dairy cows 
(Grummer et al., 1990), the risk to development of metabolic disease is clear. 
Additionally, postpartum concentration of C16:0, C18:0, and C18:1n-9 cis were 
significantly increased in lactating dairy cows with fatty liver, compared to levels in 
control cows (Rukkwamsuk et al., 2000), indicating a potential detrimental effect of these 
particular fatty acids in whole body metabolism.  
Recent research has extensively examined the response of PC promoter to fatty 
acids and PPARα agonist (White et al., 2011b.c), but it remains unclear the dominance of 
control of specific fatty acids on PC mRNA expression or promoter activity, and if 
changes in PC will indeed correlate to changes in oxidative pathway flux or the capacity 
of the TCA cycle.  
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CONCLUSIONS AND FUTURE DIRECTIONS 
 
 The central role that PC plays in several biosynthetic pathways is clear. Pyruvate 
carboxylase is responsible for the conversion of pyruvate to OAA, with the cellular fate 
of OAA determined by the energy status of the cell. Pyruvate carboxylase expression is 
tissue-specific due to regulation by, in bovine, three separate promoters that give rise to 
six unique 5’ UTR variants. The response of PC to physiological stressors, including and 
elevated circulating fatty acid profile, is of utmost importance to dairy cows during the 
period of negative energy balance surrounding the transition period.  
The guiding hypothesis for this dissertation is that the circulating fatty acid 
profile, and specifically the ratio of saturated to unsaturated fatty acids, influences the 
capacity for cellular oxidation and the production of OAA, through specific influences on 
PC and PC promoter 1. These data are needed to provide valuable insight into the control 
of PC and fatty acid metabolism. If the intricate balance present between the anaplerotic 
and cataplerotic roles of PC and OAA may be manipulated through plasma fatty acid 
profiles to either prevent, or better respond to, metabolic stressors inherent to the 
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CHAPTER 2.  FATTY ACID CHAIN LENGTH AND DEGREE OF 
SATURATION REGULATE EXPRESSION OF PYRUVATE 
CARBOXYLASE MESSENGER RNA IN MADIN-DARBY BOVINE KIDNEY 
CELLS AND BOVINE PRIMARY HEPATOCYTES 
ABSTRACT  
 
Pyruvate carboxylase (PC) catalyzes oxaloacetate (OAA) synthesis and links 
gluconeogenesis and the anaplerotic generation of OAA. Previous work links bovine PC 
mRNA expression to nonesterified fatty acids (NEFA). Our objective was to determine 
effects of chain length and degree of saturation through copresence of saturated and 
unsaturated fatty acids on PC mRNA. For Experiment 1, Madin-Darby bovine kidney 
(MDBK) cells were grown to 80% confluence and exposed for 24 h to either individual 
fatty acids bound to BSA (C16:0, C18:0, C18:1n-9 cis or C18:3n-3 cis) or their 
combinations at increasing molar ratios for C16:0: C18:3n-3 cis or C18:0: C18:3n-3 cis 
or C18:1n-9 cis: C18:3n-3 cis. For Experiment 2, 20 h after seeding, isolated bovine 
hepatocytes were similarly exposed for 24 h to individual fatty acids (C16:0, C18:0, or 
C18:3n-3 cis) or their combinations at increasing molar ratios for C16:0: C18:3n-3 cis or 
C18:0: C18:3n-3 cis. Total fatty acid concentration was 1.00 mM for all incubations. 
Both C16:0 and C18:0 independently decreased (P < 0.05) PC mRNA relative to control 
(0.48, 0.16, and 2.33 ± 0.48 for C16:0, C18:0, and control, respectively) in MDBK cells. 
The ratio of 75:25 C18:0: C18:3n-3 cis increased PC expression compared to C18:0
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treatment alone (1.97 vs. 0.16 ± 0.34, for 75:25 C18:0: C18:3n-3 cis, and C18:0, 
respectively; P < 0.05) in MDBK cells. The ratio of 75:25 C16:0: C18:3n-3 cis 
significantly increased PC mRNA expression compared with C16:0 alone, but only 50:50 
C16:0: C18:3n-3 cis could recover PC expression to levels similar to control (1.41, 0.48, 
2.08, and 2.33 ± 0.48 for 75:25 C16:0: C18:3n-3 cis, C16:0, 50:50 C16:0: C18:3n-3 cis, 
and control, respectively; P < 0.05) in MDBK cells. For primary bovine hepatocyte, 
exposure to C18:3n-3 cis significantly elevated (P < 0.05) PC mRNA expression relative 
to control, C16:0 or C18:0. There was no effect of C16:0, C18:0 or combinations of 
C16:0 or C18:0 with C18:3n-3 cis. Results indicate that C18:3n-3 cis is a more potent 
alleviator of PC depression in C18:0 treated MDBK cells compared to C16:0: C18:3n-3 
cis treatments. C18:1n-9 cis treatments did not depress PC (P > 0.10) in MDBK cells, 
revealing fatty acid saturation is key in PC expression. PC activation by unsaturated fatty 
acids may play a critical role in setting the capacity for OAA synthesis. 
 




Accumulation of liver lipids, known as hepatic steatosis, is a predisposing 
condition to nonalcoholic fatty liver disease and occurs from an imbalance in lipid 
synthesis and disposal (Malhi and Gores, 2008). The capacity of liver to metabolize fatty 
acids released from adipose tissue determines, at least in part, susceptibility to hepatic 
steatosis. Likewise, both the type and amount of dietary fatty acids have been shown to 
influence whole-body metabolism, as well as hepatic gene expression (Ooi et al., 2013). 
In rodents, diets high in saturated fat increase serum triglyceride levels and promote the 
development of obesity and insulin resistance (Kraegen et al., 1991). Previous studies 
show that regulation of gene expression by circulating fatty acids occurs either through 
indirect mechanisms to alter cellular metabolism or directly by acting to regulate 
transcription factor activity (Jump et al., 2013). Therefore, circulating fatty acids may 
influence susceptibility to metabolic diseases by altering responsiveness to endocrine and 
metabolic signals.  
During the transition to lactation, the 6 wk period surrounding parturition, a dairy 
cow experiences a period of negative energy balance when adipose tissues are mobilized 
and fatty acids are released into blood and transported to liver for metabolism (LeBlanc, 
2010). In dairy cows, circulating fatty acids are taken up by liver in proportion to their 
concentration in blood (Emery et al., 1992). In liver, fatty acids are metabolized and have 
one of four possible fates: complete oxidation through the tricarboxylic acid (TCA) cycle 
yielding ATP and CO2, incomplete oxidation yielding ketone bodies, transport from the 
liver as very low density lipoprotein (VLDL), or esterification for storage in liver as 
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triglycerides (reviewed by Grummer, 1993; Drackley et al., 2001; Bobe et al., 2004; van 
Knegsel et al., 2005). Because the prevalence of hepatic steatosis is over 50% in dairy 
cows with a cost to the United States dairy industry of approximately US$60 million 
annually (Bobe et al., 2004), strategies are sought to reduce the incidence and severity of 
the disease. With the inherently low capacity of ruminant liver to export VLDL (Kleppe 
et al., 1988; Armentano et al., 1991; Emmison et al., 1991,), as well as a maximum level 
for use of ketone bodies by extrahepatic tissues, a promising avenue to reduce the 
incidence of hepatic steatosis in dairy cows may be to promote alternative metabolism of 
fatty acids through oxidation to CO2. 
Pyruvate carboxylase (PC; EC 6.4.1.1) catalyzes oxaloacetate (OAA) synthesis 
and ostensibly links the cataplerotic pull of carbons away from the tricarboxylic acid 
cycle (TCA), specifically through gluconeogenesis, and the anaplerotic generation of 
OAA. Expansion of the OAA pool can increase the potential capacity of the TCA cycle 
and promote an increase in complete oxidation of acetyl-CoA as long as the activities of 
cytosolic phosphoenolpyruvate carboxykinase (PCK1) and mitochondrial 
phosphoenolpyruvate carboxykinase (PCK2) are not increased (Jitrapakdee et al., 2006). 
A reduction in PC activity has long been associated with a decrease in the pool of OAA 
in mitochondria of glucogenic tissues during increased gluconeogenesis in ketotic cows 
(Baird et al., 1968).  
Pyruvate carboxylase mRNA expression is significantly increased around the time 
of calving and during feed restriction in dairy cows while other enzymes related to 
glucose production are not affected (Greenfield et al., 2000; Velez and Donkin, 2005). 
Changes in the profile of circulating fatty acids around parturition may influence 
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gluconeogenic enzymes, including PC. Fatty acids have previously been shown to 
regulate PC gene expression in several species (Jitrapakdee et al., 2008). Previous work 
also demonstrates activation of bovine PC mRNA in response to a peroxisome 
proliferator-activated receptor-α (PPARα) agonist but a decrease with exposure to 
saturated fatty acids (White et al., 2011b).  
Diets fed to dairy cows during the dry period have been shown to alter circulating 
fatty acid profiles and concentrations at calving (Rukkwamsuk et al., 2000). Dairy cows 
with induced fatty liver postpartum had significantly greater concentrations of serum 
C16:0, C18:0, and C18:1n-9 cis relative to fatty acid serum concentrations from control 
cows (Rukkwamsuk et al., 2000). Furthermore, feeding diets rich in flaxseed, a source of 
C18:3n-3 cis, starting from 6 wk before calving significantly decreased the accumulation 
of liver triglycerides after calving compared to control cows or those receiving saturated 
fat supplements during the dry period (Petit et al., 2007), suggesting that inclusion of 
dietary C18:3n-3 cis alters hepatic fatty acid metabolism. Long chain fatty acids have 
also been shown to regulate fatty acid oxidation in rodents (Ide et al., 1996) and dietary 
fat containing high amounts of C18:3n-3 cis increased both mitochondrial and 
peroxisomal oxidation rates, as well as increased activities of enzymes related to β-
oxidation in rat liver.  
We hypothesized that bovine PC mRNA expression is differentially regulated by 
saturated and unsaturated fatty acids and the balance of fatty acids determines PC mRNA 
abundance. Our objective was to determine the effects of fatty acid chain length, degree 
of saturation, and copresence of saturated and unsaturated fatty acids on PC mRNA 
expression. We first utilized Madin-Darby bovine kidney (MDBK) cells as a model 
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system for these experiments as enzymes associated with glucogenic pathways have 
previously been studied in MDBK cells (Bionaz et al., 2008a,b; Thering et al., 2009; 
White et al., 2012). Additionally, this cell line permits prolonged exposure to fatty acids 
and other factors. A parallel experiment was completed in isolated bovine hepatocytes to 
examine the effects of fatty acids on PC mRNA expression in bovine liver.  
 
 
MATERIALS AND METHODS  
 
Experiment 1 
Cell Culture. Madin-Darby bovine kidney epithelial cells (NBL-1 ATCC CCL-
22) were obtained at passage 110 from the American Type Culture Collection (ATCC, 
Manassas, VA). Cells were propagated in sterile polystyrene 150-cm2 canted-neck, 0.2 
µm vent cap flasks (Corning, Corning, NY) in Dulbecco’s Modified Eagle’s Medium 
(DMEM) containing 1 g/L D-glucose, L-glutamine, and 110 mg/L sodium pyruvate (Life 
Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS; 
Sigma-Aldrich Corp., St. Louis, MO), 100 units/mL penicillin, 100 µg/mL streptomycin, 
and 250 ng/mL amphotericin B (Antibiotic-Antimycotic Solution; Sigma-Aldrich Corp., 
St. Louis, MO) at 37°C in 5% CO2 and 95% air. Media was refreshed every two to three 
d. Cells were subcultured to near confluence following media removal with trypsin-
EDTA (Sigma-Aldrich Corp., St. Louis, MO). Trypsin activity was inhibited by addition 
of 10 mL of fresh DMEM supplemented with 10% FBS (Sigma-Aldrich Corp.), 100 
units/mL penicillin, 100 µg/mL streptomycin, and 250 ng/mL amphotericin B 
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(Antibiotic-Antimycotic Solution; Sigma-Aldrich Corp.). For each experimental 
replicate, cells were plated on 6-well plates (Corning, Glendale, AZ) at a density of 5 × 
105 cells per 35-mm diameter well and incubated in 10% FBS DMEM with antibiotics, as 
indicated above, to achieve approximately 80% confluence before exposure to treatments. 
Fatty acid treatments. Fatty acids C16:0, C18:0, C18:1n-9 cis, C18:3n-3 cis 
(Sigma-Aldrich Corp.) were bound to BSA (Probumin; Millipore, Billerica, MA) in a 4:1 
molar ratio as described previously (Berry et al., 1991). MDBK cells at 80% confluence 
were cultured in DMEM and exposed for 24 h to either 1% BSA (no addition control), or 
to 1.0 mM individual fatty acid (bound to BSA), or to combinations of fatty acids in 
10:90, 25:75, 50:50, or 75:25 molar ratios from combinations of C16:0: C18:3n-3 cis, and 
in 25:75, 50:50, 75:25, or 90:10 molar ratios from combinations of C18:0: C18:3n-3 cis, 
or C18:1n-9 cis: C18:3n-3 cis. Total fatty acid concentration in each combination was 1.0 
mM and total BSA concentration was 1%. Treatments were applied in triplicate to three 
separate MDBK cell replicates.  
 
Experiment 2 
Care and Use of Hepatocyte Donor Animals. All experimental procedures 
involving animals were approved by the Purdue University Animal Care and Use 
Committee. Intact male dairy calves were fed colostrum at birth followed by milk diet at 
10% of birthweight and delivered as two equal portions twice daily. Animals were 
selected as hepatocyte donors within 7 d of age, were given heparin (1, 000 USP, Sagent 
Pharmaceuticals, Schaumburg, IL) intravenously and anesthetized with 1% propofol (6 
mg/kg calf body weight, Hospira Inc. Lake Forest, IL) via intravenous injection. The 
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caudate process was excised and the animals were euthanized immediately by 
intravenous injection of saturated potassium chloride (150 mg/kg calf body weight; 
Sigma-Aldrich Corp., St. Louis, MO). 
Hepatocyte Monolayer Preparation and Culture. Liver cells were dispersed via 
collagenase perfusion as described previously (Donkin and Armentano, 1993). The 
isolated hepatocytes were plated onto 35-mm Falcon Primaria Easy Grip tissue culture 
dish (Becton Dickinson, Lincoln Park, NJ) at an approximate density of 5.3 x 104 
cells/cm2 in DMEM containing 20% FBS and 100 units/mL penicillin, 100 µg/mL 
streptomycin, and 250 ng/mL amphotericin B (Antibiotic-Antimycotic Solution; Sigma-
Aldrich Corp., St. Louis, MO). After 4 h, the plating media and unattached cells were 
removed by aspiration and media was replaced with DMEM containing 10% FBS and 
1% antibiotic, antimycotic solution. Twenty hours after seeding plates, media was 
removed by aspiration and replaced with DMEM containing 1% BSA and the fatty acid 
treatments described below. 
Fatty acid treatments. Fatty acids C16:0, C18:0, C18:3n-3 cis (Sigma-Aldrich 
Corp.) were bound to BSA (Probumin; Millipore, Billerica, MA) in a 4:1 molar ratio as 
described previously (Berry et al., 1991). Twenty hours after seeding, hepatocytes were 
cultured in DMEM and exposed for 24 h to either 1% BSA (no addition control), or to 
1.0 mM individual fatty acid (bound to BSA), or to combinations of fatty acids in 10:90, 
25:75, 50:50, or 75:25 molar ratios from combinations of C16:0: C18:3n-3 cis, and in 
25:75, 50:50, 75:25, or 90:10 molar ratios from combinations of C18:0: C18:3n-3 cis. 
Total fatty acid concentration in each combination was 1.0 mM and total BSA 
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concentration was 1%. Treatments were applied in triplicate to five separate hepatocyte 
isolations.  
 
Cell Sample Collection, RNA Isolation, and Transcript Quantification 
Samples from both Experiment 1 and Experiment 2 were processed identically. 
After exposure to treatments for 24 h, media was removed and cells were disrupted and 
lysed by adding 350 µL Buffer RLT (RNeasy Mini Kit, Qiagen Inc., Germantown, MD). 
Plates were shaken on an orbital shaker (Barnstead International, Dubuque, IA) for 10 
minutes and cell lysates collected to a 1.5 mL microcentrifuge tube. Lysates were stored 
at -80°C until subsequent RNA isolation.  
Cell lysates were homogenized by vortexing and processed using the RNeasy 
Mini Kit according to manufacturer directions (Qiagen Inc., Germantown, MD). Purified 
RNA was quantified for each sample by absorbance at 260 nm using a ND-1000 
spectrophotometer (NanoDrop Technologies Inc., Wilmington, DE) and sample integrity 
was determined by the ratio of absorbance at 260 nm to 280 nm. Only samples with a 
ratio of 260:280 greater than or equal to 1.8 were used for further analysis. An aliquot of 
1 µg of purified RNA from each sample was reverse transcribed to cDNA using an 
Omniscript reverse transcriptase kit (Qiagen, Inc., Thousand Oaks, CA), random 
decamers (Ambion, Foster City, CA) and oligo-dT (Qiagen, Inc., Thousand Oaks, CA). 
Abundance of cDNA for each sample was quantified using real-time PCR, Brilliant III 
Ultra-Fast SYBR Green QPCR Master Mix (Agilent Technologies, Inc., Santa Clara, 
CA) and primers described below. A no-reverse-transcriptase template control was 
formed by combining equal quantities of purified RNA from each sample. A cDNA pool 
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was formed from equal quantities of cDNA from each sample and diluted with DNase-
free water in a 1:4 dilution series to generate a standard curve. DNase-free water served 
as the no-template control. The abundance of PC (EC 6.4.1.1), PCK1 (EC 4.1.1.32), and 
18S (NCBI Gene number 493779) mRNA was determined using quantitative real-time 
PCR. Primers were as follows: bovine PC, CCACGAGTTCTCCAACACCT (forward), 
TTCTCCTCCAGCTCCTCGTA (reverse); and bovine 18S, 
ACCCATTCGAACGTCTGCCCTATT (forward), 
TCCTTGGATTGTGGTAGCCGTTTCT (reverse). Reactions were as follows: 1 cycle at 
95°C for 3 min; 40 cycles of 95°C for 10 s, 60°C for 20 s; and 1 cycle of 95°C for 1 min, 
55°C for 30 s, and 95°C for 30 s. Reaction efficiencies were between 90% and 110% 
based on standard curve analysis. All samples, standards, and controls were analyzed in 
triplicate and mean values normalized to 18S mRNA abundance within each sample. 
Data are expressed as arbitrary units of mRNA relative to 18S abundance within sample. 
Abundance of 18S mRNA (Ct values) was not affected by treatment (P = 0.76). 
 
Assessment of Cellular Integrity 
To assess the effects of cell manipulation and fatty acid treatments on viability, 
MDBK cells were plated on 96-well cell culture plates and grown to 80% confluence. 
Media was changed after 24 h and cells were incubated for 24 h at 37° and exposed to the 
same treatment media used for assessment of RNA expression. The TACS MTT Cell 
Proliferation Assay (Trevigen, Gaithersburg, MD) was used according to the 




Data were analyzed for normality using the Univariate procedure of SAS 9.3 
(SAS Institute Inc., Cary, NC). Analyses of variance was performed using the Proc 
Mixed procedure of SAS. The model accounted for the fixed effects of treatment and the 
random effects of cell replicate. Means were considered different when P < 0.05 and 
tended to differ if 0.05 ≤ P ≤ 0.10. Tukey-Kramer studentized adjustments were used for 
multiple comparisons to separate treatment means. Data are reported as least squares 




RESULTS AND DISCUSSION 
 
Madin-Darby bovine kidney (MDBK) cells are used here to examine regulation of 
bovine PC mRNA expression by fatty acids and their combinations. The MDBK cell 
model has been used previously to study control of enzymes for gluconeogenesis and 
fatty acid metabolism, including PC (Bionaz et al., 2008a,b; Thering et al., 2009; White 
et al., 2012). Expression patterns of periparturient cow liver tissue and MDBK 
transcriptomes showed strong similarities (Bionaz et al., 2008b). Furthermore, response 
to long-chain fatty acids and to peroxisome proliferator-activated receptor agonist 
(PPAR) agonist have been evaluated in MDBK cells (Bionaz et al., 2008a). This cell 
culture system was most recently used to analyze transcript abundance of glucogenic 
genes after treatment with fatty acid profiles that mimic circulating NEFA profiles in 
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dairy cows during the periparturient period, or under a model of induced fatty liver 
(White et al., 2012).  
Analysis of cellular integrity after fatty acid treatments on MDBK cells by TACS 
MTT Cell Proliferation Assay indicated a significant (P < 0.05) reduction in cell viability 
of 13.12%, 15.78%, 12.26%, and 8.7% with the addition of 1.00 mM C16:0, C18:0, 
C18:1n-9 cis, or C18:3n-3 cis, respectively, compared to viability levels of 10% FBS-
treated controls in MDBK cells. Treatments with each fatty acid alone, at all evaluated 
concentrations (0.25 mM, 0.50 mM, 0.75 mM, or 1.00 mM) did not differ (P > 0.10) in 
viability compared to the 10% FBS or 1% BSA treatments (Figure 2.1). Treatments with 
each fatty acid alone, at all evaluated concentrations (0.25 mM, 0.50 mM, 0.75 mM, or 
1.00 mM) showed a slight, but significant decrease (P < 0.05) in viability compared to the 
combination of C18:3n-3 cis at any evaluated ratio (Figure 2.1). Despite the effects of 
single fatty acids, any evaluated combination of two fatty acids did not differ (P > 0.10) 
for cell viability measurement from the control 1% BSA DMEM or 10% FBS DMEM 
media (Figure 2.1). This indicates a more optimal environment for cellular growth and 
proliferation occurs when any two of the fatty acids evaluated here are present in the 
treatment media for MDBK cells.  
Previous work in the human hepatoblastoma HepG2 cell line demonstrated a high 
percentage of apoptosis, measured with DAPI (4’,6-diamidino-2-phenylindole 
dihydrochloride), after 24 h treatment with 0.66 mM C16:0 (Ricchi et al., 2009). Percent 
apoptosis was significantly reduced when C18:1n-9 cis was added to treatment media, 
even when total treatment concentrations equaled 1.0 or 2.0 mM (Ricchi et al., 2009). 
Similarly, when evaluated in a model of hepatic steatosis, human hepatocytes exhibited 
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decreased cell viability after treatment with C16:0 alone (Chen et al., 2014). In the same 
study, treatments containing combinations of C16:0 with C18:1n-9 cis were able to 
reduce the C16:0-induced inhibition of cell growth (Chen et al., 2014). Treatment 
combinations of C16:0 with C18:1n-9 cis were not evaluated in the current study. Fatty 
acid treatments combining C18:0 with C18:3n-3 cis have been studied in isolated rat 
primary hepatocytes (Zhang et al., 2011). While exposure of hepatocytes to 0.25 mM 
C18:0 significantly reduced MTT-measured cellular viability, co-treatment of 0.25 mM 
C18:0 with either 0.15 mM or 0.25 mM C18:3n-3 cis restored viability measurement to 
levels similar to the control (Zhang et al., 2011). This knowledge base, combined with 
data from the current study, indicates that co-incubation with more than one fatty acids 
allows greater cellular viability, potentially from more closely mimicking in vivo 
circulating fatty acid concentrations. Consequently, these data support the value of any 
effects of fatty acid combinations on PC expression or other transcripts. While decreases 
are seen in cellular viability in the current study under single fatty acid treatments, 
compared to treatment combinations of fatty acids, these decreases did not occur from 
treatments containing multiple fatty acids. Therefore, gene expression data, discussed 
below, are not likely attributed to differences in viability and are the result of fatty acid 
treatment.  
Treatment with C16:0 or C18:0 independently decreased (P < 0.05) PC mRNA 
expression compared to either C18:3n-3 cis treatment alone or the control of no 
additional fatty acid in MDBK cells (Figure 2.2). In contrast, exposure to C18:1n-9 cis or 
C18:3n-3 cis treatment alone did not differ (P > 0.10) from the control (Figure 2.2) in 
MDBK cells. Previous research in the MIN6 mouse pancreatic β-cell line demonstrated a 
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significant decrease in PC transcript abundance after 48 h treatment with either 0.4 mM 
C16:0 or 0.4 mM C18:1n-9cis (Busch et al., 2002). In the current study, a differential 
response is clearly seen in PC mRNA expression after treatment with saturated, 
compared to mono- or polyunsaturated fatty acids alone. The bovine PC gene contains 
three promoters (Agca et al., 2004) and expresses six 5’ untranslated region variants that 
are transcribed from these promoters (Hazelton et al., 2008). PC expression regulation by 
fatty acids occurs through activation of promoter 1 (White et al., 2011a). Specifically, 
responsiveness of PC promoter 1 to C18:0 was established where depression of promoter 
1 occurred with increasing concentrations, up to 1.0 mM, of C18:0 (White et al., 2011b). 
While the current study examines PC mRNA expression, it is clear that some regulation 
by fatty acids occurs. Whether this regulation occurs through changes in transcription 
factor binding or through metabolic influences remains to be elucidated.  
To determine the dominance of control of PC mRNA expression by saturated or 
unsaturated fatty acids in MDBK cells, combinations of fatty acids in 10:90, 25:75, 
50:50, or 75:25 molar ratios from combinations of C16:0: C18:3n-3 cis, and in 25:75, 
50:50, 75:25, or 90:10 molar ratios from combinations of C18:0: C18:3n-3 cis, or 
C18:1n-9 cis: C18:3n-3 cis were examined for their potential influence on PC mRNA 
expression. The ratio of 75:25 C16:0: C18:3n-3 cis significantly increased (P < 0.05) PC 
expression compared to C16:0 alone, though values were still significantly lower (P < 
0.05) than either C18:3n-3 cis treatment alone or the control of no additional fatty acid. 
Ratios of 50:50, 25:75, or 10:90 for C16:0: C18:3n-3 cis were able to significantly (P < 
0.05) recover PC mRNA expression in MDBK cells to levels similar to control or 
C18:3n-3 cis treatment. Regulation through C18:3n-3 cis is therefore stronger than 
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regulation through C16:0 as when these two fatty acids were present in equal ratios in the 
treatment media, PC mRNA expression was similar to expression after 1.0 mM C18:3n-3 
cis treatment, and greater than expression after 1.0 mM C16:0 treatment. Fatty acid 
combinations of 75:25, 50:50, or 25:75 C18:0: C18:3n-3 were able to significantly (P < 
0.05) recover PC mRNA expression to levels similar to control or C18:3n-3 cis treatment 
in MDBK cells. Again, the dominance of control on PC gene expression can be seen in 
response to lesser ratios of C18:3n-3 cis. Combinations of C18:1n-9 cis with C18:3n-3 cis 
in any ratio did not significantly (P > 0.05) alter PC mRNA expression in MDBK cells 
(Figure 2.2). Interestingly, a recent study examining the responsiveness in MDBK cells 
of several genes involved in gluconeogenesis and fatty acid oxidation, including PC, after 
6 h exposure to several different long-chain fatty acids showed no change in PC mRNA 
expression after treatment with either C16:0, C18:0, C18:1n-9 cis, or C18:3n-3 cis 
compared to control (Bionaz et al., 2012.) However, only single fatty acid treatments at 
0.15 mM were interrogated (Bionaz et al., 2012.). Additionally, an in vivo experiment 
examined effects of supplemental long-chain fatty acids from either saturated fat sources 
(Energy Booster) or fish oil supplements from around 25 d before calving to 10 d 
postpartum (Akbar et al., 2013). Pyruvate carboxylase mRNA expression was increased 
in liver biopsy samples from the control group (no supplemental long-chain fatty acids) 
postpartum compared to prepartum, while PC mRNA expression was unchanged pre- to 
postpartum with either peripartal fat supplement, but was significantly lower than control 
(Akbar et al., 2013). Concurrently, lower concentrations of C18:3n-3 cis in liver 
phospholipids at 10 d prepartum were recorded in both fat supplemented groups 
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compared to control (Akbar et al., 2013), which further supports the relationship between 
liver C18:3n-3 cis concentration and PC mRNA expression.  
Fatty acid treatments, in any examined combination, in bovine hepatocytes did 
not elicit a significant response in PC mRNA expression (P > 0.10; Figure 2.3). When PC 
mRNA expression in response to only single fatty acid treatments and control 1% BSA is 
examined, treatment with C18:3n-3 cis alone did significantly increase (P < 0.05) PC 
mRNA expression compared to the control or saturated fatty acid treatment (1.86, 1.00, 
1.04, and 0.66 ± 0.17 for C18:3n-3 cis, 1% BSA DMEM control, C16:0, and C18:0, 
respectively). These data differ from the response seen in MDBK cells in that C18:3n-3 
cis numerically increases PC mRNA expression to levels greater than 1% BSA DMEM 
control in primary hepatocytes. As the duration of treatment was identical, this difference 
may be due, in part, to the sensitivity of hepatocytes to unsaturated fatty acids, compared 
to MDBK cells. Previous work examined response of bovine hepatocytes to long-term 
fatty acid treatments over a 48 h period and found influences of fatty acids on glucose 
metabolism (Mashek and Grummer, 2003). Treatments that included C18:3n-3 cis 
increased gluconeogenesis and decreased triglyceride deposition, though PC was not 
evaluated (Mashek and Grummer, 2003). Longer incubation periods may be necessary to 
elicit a greater response to fatty acids in primary hepatocytes. The MDBK cell model 
may be more sensitive to fatty acid uptake as the 24 h treatment period was adequate in 
this model. Accordingly, we must also consider that primary hepatocytes are exposed to 
circulating fatty acid concentrations in vivo, before harvest, and were weaned off of that 
profile after isolation, while the MDBK cells are cultured in a background media 
containing very low fatty acid levels.  
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Carboxylation of pyruvate to OAA by PC maintains the pool of OAA available 
for use in the TCA cycle. Maintaining or increasing this pool is necessary to promote 
oxidative capacity in the cell. Any increase in the OAA pool that is generated by PC may 
be opposed by enzymes that pull carbons out of the OAA pool, specifically in 
gluconeogenesis by PCK1 and PCK2. Pyruvate carboxylase enzyme activity in bovine 
has been previously correlated with PC mRNA expression (Greenfield et al., 2000). 
Therefore, if activity of PC increases, and this increase is not matched by PCK activity, 
then an increase in potential cycling and oxidative capacity of the TCA may occur. 
Elevated PC expression and activity at calving in the absence of changes in PCK1 
(Greenfield et al., 2000) would favor an increased oxidative capacity and may be part of 
the adaptations that enable transition cows to metabolize greater quantities of fatty acids 
in liver.  
Mobilization of adipose tissue stores during negative energy balance around 
parturition is necessary to meet increased energy demand. Inability to cope with this 
increased NEFA load can lead to development of ketosis or fatty liver (Vernon, 2005). 
The circulating NEFA profile as well as concentration at calving are influenced by diets 
fed to dry cows (Rukkwamsuk et al., 2000). Increases in C16:0 and C18:1, presumably 
from adipose tissue lipolysis, were elevated in liver of cows with fatty liver compared to 
control animals (Rukkwamsuk et al., 2000). Changes in circulating NEFA and the 
activation of glucogenic enzymes have also been previously linked in nonruminants 
(Pawar and Jump, 2003). Long chain fatty acids are known activators of transcription 
factors, including PPARα, that regulate genes for gluconeogenesis (Pawar and Jump, 
2003). While exposure to Wy14643 (a PPARα agonist) at 0.10 mM in rat hepatoma cells 
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has previously been shown to increase the activity of a transfected bovine PC promoter 1 
(White el al., 2011b), no change in PC mRNA expression was seen in MDBK cells 
exposed for 6 h to 0.15 mM Wy14643 (Bionaz et al., 2012). Effects of other PPARα 
agonists, or the direct effects of unsaturated fatty acids on PC mRNA expression remain 
uncertain.  
The fatty acid concentrations of 1.0 mM tested in the present study are relevant 
with regards to total circulating concentrations of NEFA in dairy cows around the time of 
parturition (Rukkwamsuk et al., 1999), but are not directly applicable to most 
physiological settings because adipose triglycerides and dietary lipids are rarely 
comprised of a single fatty acid. However, during the negative energy balance associated 
with transition to lactation, plasma NEFA profiles consist predominantly of C16:0, 
C18:0, and C18:1 (Rukkwamsuk et al., 1999). Shifts that occur in the profile of plasma 
fatty acids may influence expression of genes responsible for gluconeogenesis or fatty 
acid metabolism. An increase in the concentration of plasma C18:0 has been reported in 
periparturient dairy cows (Rukkwamsuk et al., 1999). While C18:1 levels are similar 
during the pre- or post-partum periods, C18:0 levels show a peak at calving 
(Rukkwamsuk et al., 1999; Douglas et al., 2007). Increases in plasma NEFA also occur 
after supplementation with calcium soaps of long-chain fatty acids (Megalac-R) 
compared to controls (Moallem et al., 2007). Dairy cows receiving 230 g/d Megalac-R 
during the dry period and 215 g/d Megalac-R postpartum until 100 DIM had significantly 
higher plasma NEFA levels postpartum compared to cows receiving a control dry cow 
diet without supplemental fatty acids (Moallem et al., 2007). Similarly, supplementation 
of dry cow diets with calcium soaps of fatty acids from 30 d before calving through 100 d 
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postpartum increased plasma NEFA and BHBA levels compared to cows receiving 
hydrogenated palm oil triglyceride at equal net energy supply during the same period 
(Karcagi et al., 2009). Although neither of these studies were specifically designed to 
examine the influences of dietary fat on plasma fatty acid profile, data is available 
indicating the effect of feeding whole flaxseed, a source of polyunsaturated fatty acids, 
on plasma NEFA profiles (Petit, 2002). Postpartum diets containing flaxseed increased 
plasma C18:1n-9 cis and C18:3n-3 cis levels compared to plasma levels in cows 
receiving postpartum diets supplemented with micronized soybeans (Petit, 2002). Data 
from the current study indicate that stearic acid directly depresses bovine PC mRNA 
expression and suggest that the ratio of saturated to unsaturated plasma fatty acids 
regulate changes in PC mRNA around calving. When combined with observations of 
changes in fatty acid profiles at calving with diet and predisposing physiological states, a 
working hypothesis emerges that dietary fatty acid profile can determine PC expression 
to potentially alter the cellular OAA pool. Additional work is needed to better 
characterize the interplay between these fatty acids and potential effects on bovine liver.  
Results presented in the current study indicate that C18:3n-3 cis is a more potent 
alleviator of PC mRNA depression in C18:0: C18:3n-3 cis treated MDBK cells compared 
to C16:0: C18:3n-3 cis treatments. C18:1n-9 cis treatments did not depress PC mRNA 
expression, revealing that fatty acid saturation is key in fatty acid regulation of PC 
expression. These data indicate a potential differential response of unsaturated or 






Results indicate a significant depression of PC mRNA expression in MDBK cells 
after 24 h treatment with either C16:0 or C18:0. Inclusion of C18:3n-3 cis in treatment 
media, in the higher evaluated ratios, proved to successfully ameliorate this depression 
and recover PC mRNA expression to levels similar to control. Response of bovine 
hepatocytes to fatty acid exposure was muted, possibly due to duration of treatment, but 
PC mRNA expression did increase in bovine hepatocytes after C18:3n-3 cis, compared to 
single saturated fatty acid treatment or to control. PC activation by unsaturated fatty acids 
may play a critical role in setting the capacity for OAA synthesis. Both fatty acid chain 
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Figure 2.1. Effect of 24 h fatty acid treatments on cellular viability in Madin-Darby 
bovine kidney (MDBK) cells. To assess the effects of cell manipulation and fatty acid 
treatments on viability, cells were plated on 96-well cell culture plates and grown to 80% 
confluence. Media was changed after 24 h and cells were incubated for 24 h at 37° and 
exposed to treatment media. Fatty acid treatments were either single fatty acids (C16:0, 
C18:0, C18:1n-9 cis, or C18:3n-3 cis) or combinations of C16:0 with C18:3n-3 cis, or 
C18:0 with C18:3n-3 cis, or C18:1n-9 cis with C18:3n-3 cis, in the molar ratios indicated. 
All treatments totaled 1.0 mM in Dulbecco’s Modified Eagle’s Medium (DMEM) with 
1% BSA. Control cells were incubated in DMEM with 1% BSA and no additional fatty 
acid. The TACS MTT Cell Proliferation Assay (Trevigen, Gaithersburg, MD) was used 
according to the manufacturer’s directions to determine the effect of fatty acid treatment 
on cell viability. Data are reported as least squares means with associated standard errors. 
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Figure 2.2. Effect of 24 h exposure to fatty acids on expression of pyruvate carboxylase 
(PC) mRNA in Madin-Darby bovine kidney (MDBK) cells. MDBK cells at 80% 
confluence were cultured with BSA-bound fatty acids (FA) for 24 h. Fatty acid 
treatments were either single fatty acids (C16:0, C18:0, C18:1n-9 cis, or C18:3n-3 cis) or 
combinations of C16:0 with C18:3n-3 cis (top), or C18:0 with C18:3n-3 cis (middle), or 
C18:1n-9 cis with C18:3n-3 cis (bottom), in the molar ratios listed. All treatments totaled 
1.0 mM in Dulbecco’s Modified Eagle’s Medium (DMEM) containing 1% BSA. Control 
treatment is DMEM with 1% BSA and no added fatty acid. Data are presented as ratio of 
PC:18S mRNA expression in arbitrary units (AU) and reported as least squares means 
with associated standard errors. Within panel, means without a common superscript differ 
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Figure 2.3. Effect of 24 h exposure to fatty acids on expression of pyruvate carboxylase 
(PC) mRNA in bovine primary hepatocytes. Twenty hours after seeding plates, 
hepatocytes were exposed to BSA-bound fatty acids (FA) for 24 h and then harvested for 
mRNA analysis. Fatty acid treatments were either single fatty acids (C16:0, C18:0, or 
C18:3n-3 cis) or combinations of C16:0 with C18:3n-3 cis (top), or C18:0 with C18:3n-3 
cis (bottom), in the molar ratios listed. All treatments totaled 1.0 mM in Dulbecco’s 
Modified Eagle’s Medium (DMEM) containing 1% BSA. Control treatment is DMEM 
with 1% BSA and no added fatty acid. Data are presented as ratio of PC:18S mRNA 
expression, relative to 1% BSA DMEM control, in arbitrary units (AU) and reported as 
least squares means with associated standard errors. Within panel, means without a 
common superscript differ (P < 0.05). Analysis of PC mRNA expression in response to 
only single fatty acid treatments and control 1% BSA determined treatment with C18:3n-
3 cis alone significantly increased (P < 0.05) PC mRNA expression compared to the 1% 
BSA DMEM control or saturated fatty acid treatment (1.86, 1.00, 1.04, and 0.66 ± 0.17 
for C18:3n-3 cis, 1% BSA DMEM control, C16:0, and C18:0, respectively). 
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CHAPTER 3.  PRETREATMENT WITH SATURATED AND UNSATURATED 
FATTY ACIDS REGULATES SUBSEQUENT PALMITATE METABOLISM 
IN MADIN-DARBY BOVINE KIDNEY CELLS 
ABSTRACT  
 
Metabolic fates of fatty acids in tissue may be influenced by extracellular 
concentration and profile of fatty acids. Previous work has demonstrated an ability of 
C18:3n-3 cis to ameliorate the effects of C16:0- or C18:0-induced depression of pyruvate 
carboxylase (PC) mRNA expression. Pyruvate carboxylase catalyzes oxaloacetate (OAA) 
synthesis and connects gluconeogenesis from lactate and fatty acid metabolism. Our 
objective was to determine the effects of a copresence of saturated and unsaturated fatty 
acids on cellular partitioning of [1-14C]C16:0 metabolism to CO2 or acid-soluble products 
(ASP) in Madin-Darby bovine kidney (MDBK) cells and the role of PC in this 
relationship. We hypothesized that the ratio of saturated to unsaturated fatty acid 
pretreatments regulates [1-14C]C16:0 partitioning to CO2 or ASP. Cells were exposed for 
21h to either individual fatty acids, C16:0, C18:0, C18:1n-9 cis or C18:3n-3 cis, or to 
fatty acid combinations in 10:90, 25:75, 50:50, 75:25 or 90:10 ratios for combinations of 
C16:0: C18:3n-3 cis or C18:0: C18:3n-3 cis or C18:1n-9 cis: C18:3n-3 cis. Total fatty 
acid concentration was 1.0 mM during the 21 h pretreatment phase. Following the 21 h 
incubation phase with fatty acid combinations, cells were incubated in the presence of 1.0 
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mM [1-14C]C16:0 for 3h to determine the rate of metabolism to CO2 and ASP collection 
per h ∙ µg DNA-1. Pretreatments with either C16:0 or C18:0 alone significantly (P < 0.01) 
depressed subsequent oxidation of [1-14C]C16:0 to ASP by 62.7% and 41.2%, 
respectively, compared to C18:3n-3 cis pretreatments. Similar patterns were observed for 
[1-14C]C16:0 oxidation to CO2. Expression of PC mRNA was significantly decreased (P 
< 0.05) with exposure to either C16:0 or C18:0, compared to expression after exposure to 
either C18:3n-3 cis or control 1% BSA DMEM. Expression of cytosolic 
phosphoenolpyruvate carboxykinase (PCK1) mRNA followed a similar pattern. Fatty 
acid treatments containing C18:1n-9 cis did not alter PC or PCK1 expression from 
control or C18:3n-3 cis results. Pearson’s coefficient correlations were determined for PC 
mRNA expression and rate of [1-14C]C16:0 metabolism to CO2 or ASP, including 
ketones, and for PCK1 mRNA expression and rate of [1-14C]C16:0 metabolism to CO2 or 
ASP. Production of CO2 from [1-
14C]C16:0 positively correlated (r = 0.63; P < 0.05) with 
PC expression, while ASP production from [1-14C]C16:0 only tended to positively 
correlate (r = 0.51; 0.05 < P < 0.10) with PC mRNA expression. Production of CO2 or 
ASP from [1-14C]C16:0 both positively correlated (r = 0.80; r = 0.69, respectively; P < 
0.05) with PCK1 expression. Results show a regulation of ketone production by MDBK 
cells in response to saturated and unsaturated fatty acid pretreatments. 
 




Pyruvate carboxylase (PC; EC 6.4.1.1) is a critical enzyme, responsible for the 
anaplerotic regeneration of tricarboxylic acid cycle (TCA) intermediates. Conversely, 
phosphoenolpyruvate carboxykinase (PCK; EC 4.1.1.32) acts to cataplerotically drain 
carbon intermediates from TCA cycle towards gluconeogenesis. Pyruvate carboxylase is 
responsible for the carboxylation of pyruvate to oxaloacetate (OAA), which subsequently 
condenses with acetyl-CoA in the first step of the TCA cycle, therefore, the capacity for 
fatty acid oxidation as well as gluconeogenesis is dependent upon the OAA status within 
the cell. As a result, the maintenance of the OAA pool through the action of PC flux 
could promote complete oxidation of acetyl-CoA in the TCA cycle, providing PCK1 and 
PCK2 activities do not exceed PC flux (Jitrapakdee et al., 2006).  
Nutritional control of PC is well established in rats (Bizeau et al., 2001), mice 
(Hagopian et al., 2004), and lactating dairy cows, specifically during a period of imposed 
feed restriction (Velez and Donkin 2005), and transition to lactation (Greenfield et al., 
2000). In periparturient dairy cows, plasma nonesterified fatty acid (NEFA) 
concentrations increase in response to the negative energy balance experienced around 
calving. After calving, plasma NEFA concentrations in excess of 1.5 mM are observed 
and contrast to concentrations near 0.2 mM during the prepartum period (Rukkwamsuk et 
al., 2000). Circulating NEFA are taken up by liver in proportion to their presence in 
blood (Emery et al., 1992) and are either metabolized through either complete or partial 
oxidation, or triglyceride synthesis and either deposition or loading onto very low density 
lipoprotein (VLDL) particles for export (reviewed by Drackley et al., 2001; Bobe et al., 
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2004; van Knegsel et al., 2005). Ruminants and nonruminants differ with respect to 
hepatic capacity for VLDL export, with the rate of export by nonruminants being 25 
times the capacity of VLDL export for ruminants (Kleppe et al., 1988). Increases in 
triglyceride synthesis thus put dairy cows at increased risk for developing ketosis and 
fatty liver. Furthermore, overfeeding during the prepartum interval is linked to a decrease 
in the activity of hepatic enzymes involved in NEFA oxidation (Murondoti et al., 2004), 
and a decrease in the rate of C16:0 oxidation to CO2 (Litherland et al., 2011). Strategies 
to alleviate these pathways of fatty acid metabolism and promote alternative fatty acid 
oxidative pathways could potentially decrease susceptibility to these metabolic disorders. 
The role of PC mRNA expression in relation to the potential for cellular complete 
or partial fatty acid oxidation remains unclear. Our objective was therefore to determine 
effects of copresence of saturated and unsaturated fatty acid pretreatments on cellular 
partitioning of [1-14C]C16:0 metabolism to CO2 or acid-soluble products (ASP) in Madin-
Darby bovine kidney (MDBK) cells, a bovine model cell line for the study of cellular 
energy metabolism. We hypothesized that the ratio of saturated to unsaturated fatty acid 
pretreatments regulates [1-14C]C16:0 partitioning to CO2 and ASP.  
 
 
MATERIALS AND METHODS  
 
Cell Culture  
Madin-Darby bovine kidney epithelial cells (NBL-1 ATCC CCL-22) were 
obtained at passage 110 from the American Type Culture Collection (ATCC, Manassas, 
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VA). Cells were propagated in sterile polystyrene 150-cm2 canted-neck, 0.2 µm vent cap 
flasks (Corning, Corning, NY) in Dulbecco’s Modified Eagle’s Medium (DMEM) 
containing 1 g/L D-glucose, L-glutamine, and 110 mg/L sodium pyruvate (Life 
Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS; 
Sigma-Aldrich Corp., St. Louis, MO), 100 units/mL penicillin, 100 µg/mL streptomycin, 
and 250 ng/mL amphotericin B (Antibiotic-Antimycotic Solution; Sigma-Aldrich Corp., 
St. Louis, MO) at 37°C in 5% CO2 and 95% air. Media was refreshed every two to three 
d. Cells were subcultured to near confluence following media removal with trypsin-
EDTA (Sigma-Aldrich Corp., St. Louis, MO). Trypsin activity was inhibited by addition 
of 10 mL of fresh DMEM supplemented with 10% FBS (Sigma-Aldrich Corp.), 100 
units/mL penicillin, 100 µg/mL streptomycin, and 250 ng/mL amphotericin B 
(Antibiotic-Antimycotic Solution; Sigma-Aldrich Corp.). For each experimental 
replicate, cells were plated onto 35-mm Falcon Primaria Easy Grip tissue culture dishes 
(Becton Dickinson, Lincoln Park, NJ) at a density of 5 × 105 cells per well and incubated 
in 10% FBS DMEM with antibiotics, as indicated above, to achieve approximately 80% 
confluence before exposure to treatments. 
 
Fatty acid pretreatments 
Fatty acids C16:0, C18:0, C18:1n-9 cis, C18:3n-3 cis (Sigma-Aldrich Corp.) were 
bound to BSA (Probumin; Millipore, Billerica, MA) in a 4:1 molar ratio as described 
previously (Berry et al., 1991). Cells at 80% confluence were cultured in DMEM and 
exposed for 21 h to either 1% BSA (no addition control), or to 1.0 mM individual fatty 
acid (bound to BSA), or to combinations of fatty acids in 10:90, 25:75, 50:50, or 75:25 
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molar ratios from combinations of C16:0: C18:3n-3 cis, and in 25:75, 50:50, 75:25, or 
90:10 molar ratios from combinations of C18:0: C18:3n-3 cis, or C18:1n-9 cis: C18:3n-3 
cis. Total fatty acid concentration in each combination was 1.0 mM and BSA 
concentration was 1%. Pretreatments were applied in triplicate to three separate cell 
replicates. 
 
Measurement of metabolic flux 
Following exposure to pretreatments for 21 h, cells were incubated in the 
presence of DMEM containing 1% BSA and 1.0 mM [1-14C]C16:0 for 3h before CO2 and 
ASP collection, as previously described (Donkin and Armentano, 1994). Briefly, 
pretreatment media was removed and each 35-mm dish (base) was placed into a straight-
side wide-mouth 60-mL jar (Nalgene, Thermo Scientific, Waltham, MA) with lids 
modified to hold rubber plug-type stoppers (Kimble Chase, Vineland, NJ) and fitted with 
a hanging plastic center well (Kimble Chase, Vineland, NJ). MDBK cells were then 
incubated in DMEM containing 1% BSA and 1.0 mM BSA-bound C16:0 containing 1-
14C labelled C16:0 (Perkin Elmer, Waltham, MA) at approximately 1,000,000 DPM per 
flask. Cells were gassed with 95% O2 : 5% CO2, immediately sealed and incubated at 
37°C for 3 h. Incubations were terminated by the addition of 0.2 mL of 5N HClO4 
injected through the stopper of the flask into the media. A volume of 0.2 mL 
phenethylamine was added to each hanging center well containing a filter paper wick to 
trap 14CO2. Samples were incubated for 1 h at room temperature after which center wells 
were removed, placed in scintillation vials with scintillation cocktail (Ecolite; MP 
Biomedical LLC, Solon, OH), and radioactivity determined by liquid scintillation 
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counting. The rate of fatty acid incorporation into ASP was determined from acidified 
media. Media was removed from plates, collected in 15 mL conical tubes and plates were 
rinsed 2× with ice cold saline and the saline rinse combined with acidified media. The 
collected media and saline mixture was centrifuged for 10 min at 700 × g, neutralized 
with KOH, and radioactivity determined by liquid scintillation counting. DNA content of 
each culture plate was determined as previously described (Labarca and Paigen, 1980). 
The rate of oxidation was determined and expressed as nmol 14C substrate metabolized to 
14CO2 • μg DNA
-1 • h-1. The rate of synthesis of ASP, including ketones, is expressed as 
nmol 14C substrate incorporated in ASP • μg DNA-1 • h-1. 
 
Cell Sample Collection, RNA Isolation, and Transcript Quantification 
A parallel incubation was completed utilizing the same passage of cells 
interrogated for the oxidation experiment. Cells were exposed to C16:0: C18:3n-3 cis or 
C18:0: C18:3n-3 cis fatty acid treatment combinations in the molar ratios describe above. 
After exposure to treatments for 24 h, media was removed and cells were disrupted and 
lysed by adding 350 µL Buffer RLT (RNeasy Mini Kit, Qiagen Inc., Germantown, MD). 
Plates were shaken on an orbital shaker (Barnstead International, Dubuque, IA) for 10 
minutes and cell lysates collected to a 1.5 mL microcentrifuge tube. Lysates were stored 
at -80°C until subsequent RNA isolation. 
Cell lysates were homogenized by vortexing and processed using the RNeasy 
Mini Kit according to manufacturer directions (Qiagen Inc., Germantown, MD). Purified 
RNA was quantified for each sample by absorbance at 260 nm using a ND-1000 
spectrophotometer (NanoDrop Technologies Inc., Wilmington, DE) and sample integrity 
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was determined by the ratio of absorbance at 260 nm to 280 nm. Only samples with a 
ratio of 260:280 greater than or equal to 1.8 were used for further analysis. An aliquot of 
1 µg of purified RNA from each sample was reverse transcribed to cDNA using an 
Omniscript reverse transcriptase kit (Qiagen, Inc., Thousand Oaks, CA), random 
decamers (Ambion, Foster City, CA) and oligo-dT (Qiagen, Inc., Thousand Oaks, CA). 
Abundance of cDNA for each sample was quantified using real-time PCR, Brilliant Ⅲ 
Ultra-Fast SYBR Green QPCR Master Mix (Agilent Technologies, Inc., Santa Clara, 
CA) and primers described below. The no-reverse-transcriptase template control was 
formed by combining equal quantities of purified RNA from each sample. A cDNA pool 
was formed from equal quantities of cDNA from each sample and diluted with DNase-
free water in a 1:4 dilution series to generate a standard curve. DNase-free water served 
as the no-template control. The abundance of PC (EC 6.4.1.1), PCK1 (EC 4.1.1.32), and 
18S (NCBI Gene number 493779) mRNA was determined using quantitative real-time 
PCR. Primers were as follows: bovine PC, CCACGAGTTCTCCAACACCT (forward), 
TTCTCCTCCAGCTCCTCGTA (reverse); bovine PCK1, 
AGGGAAATAGCAGGCTCCAGGAAA (forward), 
CACACGCATGTGCACACACACATA (reverse); and bovine 18S, 
ACCCATTCGAACGTCTGCCCTATT (forward), 
TCCTTGGATTGTGGTAGCCGTTTCT (reverse). Reactions were as follows: 1 cycle at 
95°C for 3 min; 40 cycles of 95°C for 10 s, 60°C for 20 s; and 1 cycle of 95°C for 1 min, 
55°C for 30 s, and 95°C for 30 s. Reaction efficiencies were between 90% and 110% 
based on standard curve analysis. All samples, standards, and controls were analyzed in 
triplicate and mean values normalized to 18S mRNA abundance within each sample. 
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Data are expressed as arbitrary units of mRNA relative to 18S abundance within sample. 
Abundance of 18S mRNA (Ct values) was not affected by treatment (P = 0.77). 
 
Statistical Analysis 
Data were analyzed for normality using the Univariate procedure of SAS 9.3 
(SAS Institute Inc., Cary, NC). Analyses of variance was performed using the Proc 
Mixed procedure of SAS. The model accounted for the fixed effects of fatty acid 
pretreatment and the random effects of cell replicate. Means were considered different 
when P < 0.05 and tended to differ if 0.05 ≤ P ≤ 0.10. Tukey-Kramer studentized 
adjustments were used for multiple comparisons to separate treatment means. Data are 
reported as least squares means with associated standard errors. Pearson correlation 
coefficients for PC mRNA expression and nmol [1-14C]C16:0 substrate conversion to 
either CO2 or ASP (per μg DNA
-1 • h-1) were obtained using the PROC CORR procedure 
of SAS (SAS Institute, Cary, NC). 
 
 
RESULTS AND DISCUSSION 
 
Use of the Madin-Darby bovine kidney (MDBK) cell line for the current study is 
supported by previous studies examining metabolism and activities of enzymes for 
gluconeogenesis and fatty acid oxidation (Bionaz et al., 2008a,b; Thering et al., 2009; 
White et al., 2012). Notable similarities have been illustrated between mRNA expression 
patterns in MDBK cells and liver from periparturient dairy cows (Bionaz et al., 2008b). 
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The metabolic role of kidney to oxidize fatty acids, especially during times of increase 
circulating NEFA load (Salto et al., 1996; Huang et al., 2006) further justifies the use of a 
kidney cell line for the current substrate oxidation experiments.  
Similar to results presented in CHAPTER 2, effects of fatty acids on expression of 
PC mRNA were evaluated. Expression of PC mRNA was significantly decreased (P < 
0.05) after exposure to 1.0 mM C16:0 or C18:0, compared to mRNA expression after to 
exposure to C18:3n-3 cis or to control 1% BSA DMEM (Table 3.1). To ameliorate this 
saturated fatty acid-induced depression, treatment ratios greater than or equal to 0.25:0.75 
C18:0: C18:3n-3 cis or 0.50:0.50 C16:0: C18:3n-3 cis were required to restore PC mRNA 
expression to levels similar (P > 0.10) to those after 1.0 mM C18:3n-3 cis treatment 
(Table 3.1). Expression of PC mRNA did not differ (P > 0.10) after exposure, at any 
ratio, to C18:1n-9 cis. To better determine to balance of cataplerotic and anaplerotic 
response occurring after exposure to fatty acid treatments, PCK1 mRNA expression was 
also determined. Expression of PCK1 mRNA was significantly decreased (P < 0.05) after 
exposure to 1.0 mM C16:0 or C18:0, compared to mRNA expression after exposure to 
C18:3n-3 cis or to control 1% BSA DMEM (Table 3.1). Treatment ratios greater than or 
equal to 0.75:0.25 C16:0: C18:3n-3 cis or C18:0: C18:3n-3 cis were required to restore 
PCK1 mRNA expression to levels similar (P > 0.10) to those after 1.0 mM C18:3n-3 cis 
treatment (Table 3.1). Similar to results from PC mRNA expression, treatments including 
any ratio of C18:1n-9 cis did not alter PCK1 mRNA expression. Maintenance of activity 
or increase activity of either enzyme, using a proxy measure of mRNA expression 
(Greenfield et al., 2000), can be used to infer the pool size available for the cataplerotic 
or anaplerotic fate of OAA.  
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Fatty acid β-oxidation occurs in both the mitochondria and peroxisome and 
effectively shortens fatty acids by two carbons with each cycle. Fatty acid pretreatments 
in the current substrate oxidation study with either 1.0 mM C16:0 or C18:0 alone 
significantly (P < 0.01) depressed subsequent oxidation of [1-14C]C16:0 to ASP by 
62.7% and 41.2%, respectively, compared to C18:3n-3 cis pretreatments in MDBK cells 
(Figure 3.1, 3.2). Similar patterns were seen for [1-14C]C16:0 oxidation to CO2. It is well 
established in rodent models that polyunsaturated acids are capable of causing increases 
in both mitochondrial and peroxisomal oxidation, while leading to a decrease in 
esterification to triglycerides (Ikeda et al., 1998; Ide et al., 2000). Early studies in 
ruminants examining metabolism of C16:0 to CO2 or ASP using bovine liver slices noted 
decreased oxidation to CO2 in liver samples from fasted, compared to control, animals, 
while fasting has no effect on C16:0 metabolism to ASP (Jesse et al., 1986). Dairy cows 
receiving a high fat diet during the dry period exhibited lower total liver lipid 
accumulation and lower liver triglyceride deposition during the postpartum period 
compared to cows receiving an isocaloric high grain dry period diet, or to the control 
(Grum et al., 1996). The fat source was provided from 50 d prepartum and was comprised 
mainly of 42% C18:1n-9 cis, 24% C16:0, 14% C18:0, 8% C18:2n-6 cis, less than 1% 
C18:3n-3 cis, and other fatty acid sources (Grum et al., 1996). The same study illustrated 
increased prepartum plasma NEFA concentrations, but decreased postpartum plasma 
NEFA concentrations in the high fat group, compared to the high grain or control groups 
(Grum et al., 1996). While total β-oxidation of C16:0 did not differ in liver tissue samples 
taken from the high grain, high fat, or control fed cows, the rate of peroxisomal β-
oxidation of C16:0 was significantly higher in samples from cows receiving the high fat 
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diet (Grum et al., 1996). Mitochondrial and peroxisomal β-oxidation were not separately 
measured in the current study, but peroxisomal β-oxidation has been shown to be 
elevated during diabetes and excess NEFA mobilization (Osmundsen et al., 1991). This 
suggests that fatty acid β-oxidation is adjustable at transition as a potential mechanism for 
transition cows to cope with the excess NEFA load experienced during this period. 
Therefore, ways to increase fatty acid β-oxidation through the fatty acid profile to which 
cells are exposed is of utmost interest.  
Treatment fatty acid levels in the current study totaled 1.0 mM and are consistent 
with circulating NEFA levels in transition dairy cows (Rukkwamsuk et al., 1999). In 
contrast with a normal physiological setting, treatments of single fatty acids alone are 
included in the current study to evaluate the effect of individual fatty acids on subsequent 
partitioning and metabolism. Plasma NEFA profiles during the periparturient period are 
primarily comprised of C16:0, C18:0, and C18:1 fatty acids, and C18:0 levels have been 
shown to peak at calving while C18:1 levels are similar pre- and post-partum 
(Rukkwamsuk et al., 1999; Douglas et al., 2007). These data merited selection of the fatty 
acids interrogated in the current study.  
The ability to increase the cellular capacity for NEFA β-oxidation has been 
extensively discussed (Drackley and Andersen, 2006). Potential influences to NEFA 
oxidation have been examined through effects of pyruvate (Armentano et al., 1991; 
Drackley et al., 1991; Lomax et al., 1983), which raises the question of relationship to PC 
activity and links to the current research. Addition of pyruvate to isolated hepatocytes 
from fasted and fed sheep stimulated C16:0 complete oxidation to CO2 (Lomax et al., 
1983). Pyruvate was shown to decrease triglyceride accumulation from C18:1n-9 cis in 
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isolated hepatocytes from lactating goats (Armentano et al., 1991). A comprehensive 
study of biopsy samples from multiparous dairy cows also demonstrated the ability of 
pyruvate to increase C16:0 oxidation (Drackley et al., 1991). Any alterations to PC 
mRNA expression or enzyme activity concurrent with changes in NEFA metabolism 
were not examined in previous studies, so the direct influence of NEFA on PC activity or 
flux toward anaplerosis or cataplerosis was not determined.  
Previous research in rodents examined the effects of dietary sources of long chain 
fatty acids and their influence on β-oxidation (Malewiak et al., 1988; Kumamoto and Ide, 
1998). Metabolism of C18:1n-9 cis in isolated hepatocytes from fat-fed rats resulted in an 
increase in ASP formation and an increase in esterification to triglycerides compared to 
isolated hepatocytes from control animals (Malewiak et al., 1988). While data from the 
current study demonstrates significantly (P < 0.05) greater production of ASP from [1-
14C]C16:0 compared to CO2 for all fatty acid pretreatments examined (Figure 3.1, 3.2, 
3.3), production of CO2 from [1-
14C]C16:0 was greater after fatty acid pretreatment with 
C18:1n-9 cis alone, compared to pretreatment combinations containing C18:3n-3 cis 
(Figure 3.3). Interestingly, increased rates of both mitochondrial and peroxisomal C16:0 
oxidation are seen in isolated hepatocytes from rats fed a fat mixture high in 18:3n-3 cis, 
compared to C16:0 oxidation from rats fed sources of C16:0 or C18:2n-6 cis (Kumamoto 
and Ide, 1998), indicating the potential for differences in responses to fatty acids between 
ruminants and nonruminants, or differences between in vitro experiments and those 
examining dietary fat sources.  
Pearson’s coefficient correlations were used to associate PC mRNA expression 
and rate of [1-14C]C16:0 metabolism to CO2 or ASP, including ketones. Production of 
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CO2 from [1-
14C]C16:0 positively correlated (r = 0.63, P < 0.05) with PC expression, 
while ASP production from [1-14C]C16:0 only tended to positively correlate (r = 0.51, 
0.05 < P < 0.01) with PC mRNA expression (Figure 3.4). Previous research using bovine 
primary hepatocytes examined the effects of 3 h exposure to C16:0 alone, or concurrent 
exposure to C16:0 combined with several different unsaturated fatty acids, on subsequent 
mitochondrial and peroxisomal oxidation (Mashek et al., 2002). Results demonstrate 
increased oxidation of fatty acids to CO2 when treatment combinations of C16:0 with 
either C20:5n-3 cis (eicosapentaenoic acid; EPA) or C22:6n-3 cis (docosahexaenoic acid; 
DHA) were introduced to hepatocytes for 3h, compared to fatty acid treatments of C16:0 
alone or C16:0 with C18:1 (Mashek et al., 2002). Similarly, 3 h treatment of bovine 
hepatocytes with C16:0 with either C18:3, C20:5n-3 cis, or C22:6n-3 cis reduced total 
cellular lipid deposition from C16:0 metabolism (Mashek et al., 2002). Results also 
indicated that polyunsaturated fatty acids, including C18:3n-3 cis, were poor substrates 
for esterification to triglycerides (Mashek et al., 2002). Although esterification of 
substrates to triglyceride formation was not measured in the current study, limitation of 
triglyceride formation by C18:3n-3 cis in a primary hepatocyte model illustrates the 
potential for promotion through other fates, namely oxidation, of fatty acids after C18:3n-
3 cis exposure in bovine. While a very similar experiment was completed after 48h 
treatments in hepatocyte monolayer cultures, the system did not concurrently measure 
complete oxidation to CO2, and only data for ASP production is available (Mashek and 
Grummer, 2003). Treatment of bovine hepatocytes with C18:0 included in the treatment 
media resulted in the highest rates of ASP production from C16:0 (Mashek and 
Grummer, 2003). Taken together, these data indicate a potential role for saturated fatty 
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acid in the promotion of substrate metabolism to ASP, perhaps linked to unsaturated fatty 
acid as a poor substrate for triglyceride esterification and promotion of substrate 
metabolism to CO2.  
Studies examining the influence of C18:3n-3 cis on hepatic fatty acid metabolism 
in rodents indicate that rats fed linseed oil had increased activity of enzymes involved in 
mitochondrial and peroxisomal β-oxidation when fed this source of C18:3n-3 cis (Kabir 
and Ide, 1996). Enzymes for fatty acid oxidation were also increased in rats fed C18:3n-3 
cis enzyme activity from rats receiving dietary sources of either C18:2n-6 cis or C16:0 
(Kumamoto and Ide, 1998). These data further support the role for C18:3n-3 cis in 
promoting fatty acid oxidation pathways.  
Finally, Pearson’s coefficient correlations were also used to associate PCK1 
mRNA expression and rate of [1-14C]C16:0 metabolism to CO2 or ASP. Production of 
CO2 or ASP from [1-
14C]C16:0 both positively correlated (r = 0.80; r = 0.69, 
respectively; P < 0.05) with PCK1 expression (Figure 3.5). Understanding the balance of 
PC and PCK1 activities is key to determine the net anaplerotic or cataplerotic pull of 
TCA cycle carbons. To maximize the energy production potential of both systems, there 
is a need to identify agents or combinations of agents that independently activate PC to 
promote fatty acid β-oxidation and TCA cycle capacity. Such an agent would, 
simultaneously, maintain, but not increase, PCK1 activity to fulfill the need for carbon 
pull to gluconeogenesis.  
The present data establish a relationship between regulation of PC mRNA 
expression by fatty acids and cellular oxidative capacity. While additional research is 
needed to establish the mechanisms through which fatty acids act to modulated PC 
96 
mRNA expression, evidence is accumulating for a role of peroxisome proliferator-
activated receptor α (PPARα). Research on hepatocyte isolations from 7-wk-old calves 
after 5 d administration of either fish oil or clofibrate, a PPARα agonist, found an 
increased rate of C16:0 conversion to CO2 in 8 h incubations from clofibrate-treated 
calves, compared to fish oil- or control-treated hepatocyte isolations (Litherland et al., 
2010), indicating an increase in capacity for fatty acid β-oxidation. An even greater 
increase in substrate oxidation to CO2 is seen in lactating goats treated with Wy-14643, a 
known PPARα agonist (Cappon et al., 2002). Furthermore, previous research from our 
laboratory indicates a response of bovine PC proximal promoter to PPARα agonist 
(White et al., 2011). Increased mRNA expression of acyl-CoA dehydrogenase and 
PPARα are both during early lactation (Loor et al., 2005) and may link increases in PC at 
calving to elevated fatty acid β-oxidation in transition cows. In further support of this 
aspect, increases in mRNA expression for genes involved in fatty acid β-oxidation, 
including acyl-CoA synthetase long chain, carnitine palmitoyl-transferase 1A, and acyl-
CoA dehydrogenase very long chain, are seen after parturition in liver samples from 
transition dairy cows (Loor, 2010; Weber et al., 2013). 
A working hypothesis for role of PC in determining cellular partitioning of fatty 
acid metabolism to either complete or partial oxidation is supported by the correlation of 
PC mRNA expression to substrate oxidation to CO2. Additional experiments are needed 
to determine if a similar relationship holds for bovine liver as for the MDBK cell model 






Results show a regulation of ketone production by MDBK cells in response to 
saturated and unsaturated fatty acid pretreatments. While oxidation of [1-14C]C16:0 to 
either CO2 or ASP was depressed by treatments with saturated fatty acids C16:0 or C18:0 
alone, correlation of CO2 values to PC mRNA expression does indicate potential for 
increased anaplerotic flux of substrates through PC, but the tendency for correlation of 
ASP oxidation values to PC mRNA expression infers either inadvertent activation of 
enzymes involved in ketogenesis, or activation of other enzymes, including PCK1, 
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Table 3.1. Pyruvate carboxylase (PC) and cytosolic phosphoenolpyruvate carboxykinase (PCK1) mRNA expression after 24 h 
exposure to fatty acid treatments in Madin-Darby bovine kidney (MDBK) cells. 
 Fatty acid treatment ratio1  
 C16:0 0.00 1.00 0.90 0.75 0.50 0.25 0.10 0.00  
Transcript2 C18:3n-3 cis 0.00 0.00 0.10 0.25 0.50 0.75 0.90 1.00 SEM 
PC  2.42a 0.36c ND3 1.33b 1.97ab 2.41a 2.36a 2.29a 0.36 
PCK1  2.13a,b 0.25e ND 1.02d 1.65bcd 2.17abc 2.31ab 2.53a 0.27 
           
 Fatty acid treatment ratio  
 C18:0 0.00 1.00 0.90 0.75 0.50 0.25 0.10 0.00  
 C18:3n-3 cis 0.00 0.00 0.10 0.25 0.50 0.75 0.90 1.00  
PC  2.42a 0.13b 0.46b 2.01a 2.13a 2.26a ND 2.29a 0.32 
PCK1  2.13b,c 0.06e 0.59de 1.28d 1.60cd 3.19a ND 2.53ab 0.30 
           
 Fatty acid treatment ratio  
 C18:1n-9 cis 0.00 1.00 0.90 0.75 0.50 0.25 0.10 0.00  
 C18:3n-3 cis 0.00 0.00 0.10 0.25 0.50 0.75 0.90 1.00  
PC  2.42 2.34 2.13 2.27 2.09 2.51 ND 2.29 0.39 
PCK1  2.13 2.02 1.98 1.87 1.92 2.28 ND 2.53 0.44 
a-eWithin fatty acid treatment ratio panel, means with different superscripts within transcript are significantly different (P < 0.05). 
1Fatty acid treatments were either single fatty acids (C16:0, C18:0, C18:1n-9 cis, or C18:3n-3 cis) or combinations of C16:0 with 
C18:3n-3 cis (top), or C18:0 with C18:3n-3 cis (middle), or C18:1n-9 cis with C18:3n-3 cis (bottom) in the molar ratios listed. All 
treatments totaled 1.0 mM in Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% BSA. Control treatment is DMEM with 1% 
BSA and no additional fatty acid. 
2Data are presented as ratio of PC:18S mRNA expression or ratio of PCK1:18S mRNA expression (Arbitrary Units). Data are 
reported as least squares means with associated standard errors. 




































C16:0 - 1.00 - 0.75 0.50 0.25 0.10 -  
C18:3n-3 cis - - - 0.25 0.50 0.75 0.90 1.00  
 Fatty acid pretreatment (mM) 
 
 
Figure 3.1. Oxidation of [1-14C]C16:0 to CO2 or acid-soluble products (ASP) after 
pretreatment with C16:0 and C18:3n-3 cis. Oxidation by Madin-Darby bovine kidney 
(MDBK) cells was measured over a 3 h period after 21 h pretreatments with BSA-bound 
fatty acids (FA). Fatty acid pretreatments were either single fatty acids (C16:0 or C18:3n-
3 cis) or combinations of C16:0 with C18:3n-3 cis in the molar ratios listed. All 
treatments totaled 1.0 mM in Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% 
BSA. Control is DMEM with 1% BSA and no additional FA. Data are reported as least 
squares means with associated standard errors. Within substrate fraction, CO2 or ASP, 

























































C18:0 - 1.00 0.90 0.75 0.50 0.25 - -  
C18:3n-3 cis - - 0.10 0.25 0.50 0.75 - 1.00  
 Fatty acid pretreatment (mM) 
 
 
Figure 3.2. Oxidation of [1-14C]C16:0 to CO2 or acid-soluble products (ASP) after 
pretreatment with C18:0 and C18:3n-3 cis. Oxidation by Madin-Darby bovine kidney 
(MDBK) cells was measured over a 3 h period after 21 h pretreatments with BSA-bound 
fatty acids (FA). Fatty acid pretreatments were either single fatty acids (C18:0 or C18:3n-
3 cis) or combinations of C18:0 with C18:3n-3 cis in the molar ratios listed. All 
treatments totaled 1.0 mM in Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% 
BSA. Control is DMEM with 1% BSA and no additional FA. Data are reported as least 
squares means with associated standard errors. Within substrate fraction, CO2 or ASP, 

























































C18:1n-9 cis - 1.00 0.90 0.75 0.50 0.25 - -  
C18:3n-3 cis - - 0.10 0.25 0.50 0.75 - 1.00  
 Fatty acid pretreatment (mM) 
 
 
Figure 3.3. Oxidation of [1-14C]C16:0 to CO2 or acid-soluble products (ASP) after 
pretreatment with C18:1n-9 cis and C18:3n-3 cis. Oxidation by Madin-Darby bovine 
kidney (MDBK) cells was measured over a 3 h period after 21 h pretreatments with BSA-
bound fatty acids (FA). Fatty acid pretreatments were either single fatty acids (C18:1n-9 
cis or C18:3n-3 cis) or combinations of C18:1n-9 cis with C18:3n-3 cis in the molar 
ratios listed. All treatments totaled 1.0 mM in Dulbecco’s Modified Eagle’s Medium 
(DMEM) with 1% BSA. Control is DMEM with 1% BSA and no additional FA. Data are 
reported as least squares means with associated standard errors. Within substrate fraction, 
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 PC mRNA expression (AU) 
(r = 0.63; P < 0.05) 
 PC mRNA expression (AU) 
(r = 0.51; 0.05 < P < 0.10) 
 
Figure 3.4. Relationship between pyruvate carboxylase (PC) mRNA expression and rate 
of C16:0 metabolism to CO2 or acid-soluble products (ASP), including ketones. MDBK 
cells at 80% confluence were cultured with BSA-bound fatty acids (FA) for 24 h (mRNA 
expression) or 21 h (substrate oxidation). Fatty acid treatments were combinations of 
fatty acids in 10:90, 25:75, 50:50, or 75:25 molar ratios from combinations of C16:0: 
C18:3n-3 cis, and in 25:75, 50:50, 75:25, or 90:10 molar ratios from combinations of 
C18:0: C18:3n-3 cis, or C18:1n-9 cis: C18:3n-3 cis. All treatments totaled 1.0 mM in 
Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% BSA. Data are reported as least 
squares means with associated standard errors. Means without a common superscript 
differ (P < 0.05). Pearson correlation coefficients for PC mRNA expression and nmol 14C 
substrate conversion to either 14CO2 or ASP (per μg DNA





































































 PCK1 mRNA expression (AU) 
(r = 0.80; P < 0.05) 
 PCK1 mRNA expression (AU) 
(r = 0.69; P < 0.05) 
 
Figure 3.5. Relationship between cytosolic phosphoenolpyruvate carboxykinase (PCK1) 
mRNA expression and rate of C16:0 metabolism to CO2 or acid-soluble products (ASP), 
including ketones. MDBK cells at 80% confluence were cultured with BSA-bound fatty 
acids (FA) for 24 h (mRNA expression) or 21 h (substrate oxidation). Fatty acid 
treatments were combinations of fatty acids in 10:90, 25:75, 50:50, or 75:25 molar ratios 
from combinations of C16:0: C18:3n-3 cis, and in 25:75, 50:50, 75:25, or 90:10 molar 
ratios from combinations of C18:0: C18:3n-3 cis, or C18:1n-9 cis: C18:3n-3 cis. All 
treatments totaled 1.0 mM in Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% 
BSA. Data are reported as least squares means with associated standard errors. Means 
without a common superscript differ (P < 0.05). Pearson correlation coefficients for 
PCK1 mRNA expression and nmol 14C substrate conversion to either 14CO2 or ASP (per 
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CHAPTER 4.  PYRUVATE CARBOXYLASE PROXIMAL PROMOTER 
ACTIVITY IS REGULATED BY SATURATED AND UNSATURATED 
FATTY ACIDS IN MADIN-DARBY BOVINE KIDNEY CELLS 
ABSTRACT  
 
An increase in bovine pyruvate carboxylase (PC; EC 6.4.1.1) at calving and 
during feed restriction corresponds with increased circulating nonesterified fatty acids 
(NEFA) as a consequence of negative energy balance. Regulation of PC mRNA and 
impact of saturated and unsaturated fatty acid profile has not yet to be explored. Our 
objective was to determine effects of chain length, degree of saturation and copresence of 
saturated and unsaturated fatty acids on activity of bovine PC promoter 1 (PCP1). For 
these experiments MDBK cells were transfected with a full length bovine PCP1 construct 
from -1002 to +3 bp relative to the bovine PC gene transcription start site (bovine PCP1(-
1002_+3)) ligated to a Firefly luciferase reporter, or with one of a series of nested 5’ serial 
truncations (bovine PCP1(-773_+3), bovine PCP1(-494_+3), or bovine PCP1(-222_+3)). Cells 
were exposed for 23 h to either individual fatty acids bound to BSA (C16:0, C18:0, or 
C18:3n-3 cis) or to fatty acid mixtures in ratios of 75:25, 50:50, or 25:75 corresponding 
to combinations of C16:0: C18:3n-3 cis or C18:0: C18:3n-3 cis. Total fatty acid 
concentration was 1.00 mM. Exposure to either C16:0 or C18:3n-3 cis alone elicited a 
significant (P < 0.05) increase in bovine PCP1(-1002_+3) activity compared to 1% BSA  
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DMEM control treatment (33.97, 50.05, and 19.64 ± 6.15 Fold of promoter induction 
(AU) for C16:0, C18:3n-3 cis, and control, respectively). Treatment with C18:3n-3 cis 
alone caused a greater increase (P < 0.05) in promoter activity compared to C16:0 alone, 
indicating a lesser response to C16:0 alone. Interestingly, inclusion of C18:3n-3 cis, at 
any level in fatty acid ratios examined, increased promoter activity of bovine PCP1(-
773_+3) or bovine PCP1(-222_+3) compared to activity of bovine PCP1(-1002_+3). Data from the 
bovine PCP1 truncation and fatty acid copresence experiments reveal the potential for 
response elements of unsaturated fatty acids or fatty acid ligands in several bovine PCP1 
promoter regions. In silico analysis of bovine PCP1 identified putative peroxisome 
proliferator-activated receptor (PPAR) α and sterol regulatory element binding protein 
(SREBP) binding sites which may be implicated in fatty acid signaling to alter bovine 
PCP1 activity. Pyruvate carboxylase promoter 1 activity that is mediated by unsaturated 
fatty acids acting through elements within -1002 and -222 of bovine PCPI, may 
determine PC response during periods of negative energy balance in dairy cows. 
 





Pyruvate carboxylase (PC; EC 6.4.1.1) plays a central role in the anaplerotic 
supply of oxaloacetate (OAA) for the tricarboxylic acid (TCA) cycle and the cataplerotic 
supply of carbons for gluconeogenesis. Expression of PC mRNA is significantly elevated 
in dairy cows around the time of calving and during feed restriction, and has been linked 
to increased fatty acid concentrations (Greenfield et al., 2000; Velez and Donkin, 2005; 
White et al., 2011a,b). Diets fed during the prepartum interval alter both the 
concentration and profile of plasma fatty acids in dairy cows at calving (Rukkwamsuk et 
al., 2000; Douglas et al., 2007; Petit et al., 2007). Likewise, changes in PC mRNA during 
feed restriction are linked to changes in serum fatty acid concentrations and profiles 
(White et al., 2011b) and these effects are mediated through promoter 1 and located 
proximal to the transcription start site (PCP1) of the bovine PC gene. However, there 
appears to be opposing effects of saturated fatty acids on PC promoter activity (White et 
al., 2011b,c).  
Regulation of PC gene expression by fatty acids has been characterized in several 
species and appears to be linked through peroxisome proliferator-activated receptors 
(PPAR; Jitrapakdee et al., 2008). The contrasting effects of unsaturated fatty acids and 
saturated fatty acids that serve as PPAR agonists and antagonists for bovine PC may be a 
consequence of differences in modes of signaling for these fatty acids and cross talk that 
involve sterol regulatory element binding protein (SREBP)-1c and liver X receptor 
(LXR; Yoshikawa et al., 2003). Direct effects of saturated and unsaturated fatty acids and 
the interplay between these fatty acids on bovine PCP1 have not been fully elucidated. 
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Based on previous data indicating opposing effects of C18:0 and C18:3n-3 cis on bovine 
PC mRNA, we hypothesized that fatty acid profile, and specifically the ratio of saturated 
to unsaturated fatty acids, regulates the activity of bovine PCP1. Our objective was to 
determine the effects of fatty acid chain length and degree of saturation and the 
copresence of saturated and unsaturated fatty acids on the activity of bovine PCP1. 
Madin-Darby bovine kidney (MDBK) cells were utilized in the current study. Previous 
research on enzymes associated with gluconeogenic pathways in MDBK cells (Bionaz et 
al., 2008a,b; Thering et al., 2009; White et al., 2012), and examination of the 
transcriptomes of MDBK cells compared to bovine liver (Bionaz et al., 2008b) support 
the use of this cell model system.  
 
 
MATERIALS AND METHODS  
 
Cell Culture  
Madin-Darby bovine kidney epithelial cells (NBL-1 ATCC CCL-22) were 
obtained at passage 110 from the American Type Culture Collection (ATCC, Manassas, 
VA). Cells were propagated in sterile polystyrene 150-cm2 canted-neck, 0.2 µm vent cap 
flasks (Corning, Corning, NY) in Dulbecco’s Modified Eagle medium (DMEM) 
containing 1 g/L D-glucose, L-glutamine, and 110 mg/L sodium pyruvate (Life 
Technologies, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS; 
Sigma-Aldrich Corp., St. Louis, MO), 10 mg/L piperacillin (Sigma-Aldrich Corp.), and 
10 mg/L ciprofloxacin (Sigma-Aldrich Corp.), at 37°C in 5% CO2 and 95% air. Media 
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was refreshed every two to three d. Cells were subcultured to near confluence following 
media removal with trypsin-EDTA (Sigma-Aldrich Corp., St. Louis, MO). Trypsin 
activity was inhibited by addition of 10 mL of fresh DMEM supplemented with 10% FBS 
(Sigma-Aldrich Corp.), 10mg/L piperacillin and 10mg/L ciprofloxacin. For each 
experimental replicate, cells were plated on 24-well plates (Corning, Glendale, AZ) at a 
density of 1.5 × 105 cells per 15.6-mm diameter well and incubated in 10% FBS DMEM 
with antibiotics, as indicated above, to achieve approximately 80% confluence before 
exposure to treatments. 
 
Promoter Constructs and DNA Transfections 
To test the effects of fatty acids on bovine PCP1 activity, cells were transfected 
with one of four possible promoter-luciferase constructs containing segments of bovine 
PCP1 truncated from the 5' end of the bovine PC gene and linked to a reporter gene for 
firefly luciferase. The full length construct for bovine PCP1 contained bases 613,522 
through 612,518 of bovine chromosome 29 (GenBank accession NW_00149451.1), 
which corresponds to the region from −1,001 through +3 bp relative to the transcription 
start site of bovine PCP1 (Hazelton et al., 2008). The ligated pGL3 constructs were as 
previously described (White et al., 2011c), including the full length construct of bovine 
PCP1 (PCP1(-1002_+3)), and truncations consisting of -773 through +3 bp (bovine PCP1(-
773_+3)), -494 through +3 bp (bovine PCP1(-494_+3)), and -222 through +3 bp (bovine PCP1(-
222_+3)) relative to the transcription start site, respectively.  
The pGL3 family of plasmids (Promega, Madison, WI) was utilized for the 
current experiments. The pGL3-Basic plasmid, lacking a promoter sequence, was used as 
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a negative control for transfection experiments. A luciferase reporter plasmid containing 
the SV40 promoter, pGL3-SV40, served as a positive control. Co-transfection of cells 
with a Renilla luciferase plasmid, pRL-CMV (Promega), provided a normalization 
control for transfection efficiency.  
Transient transfections in MDBK cells were performed using Lipofectamine 2000 
(Invitrogen Inc., Waltham, MA) according to the manufacturer’s instructions. For 
transfection, cells were incubated in media containing 1% BSA (Probumin; Millipore, 
Billerica, MA) without antibiotics. A volume of 100 µL of the Lipofectamine-plasmid 
mixture containing 98 µL of Opti-MEM I Reduced Serum Medium (Life Technologies 
Inc., Grand Island, NY), 2 µL of Lipofectamine, 0.8 µg of each tested plasmid and 0.008 
µg of a Renilla pRL-CMV luciferase plasmid was added to each well. Five hours after 
transfection, media was removed by aspiration, and replaced with the treatment additions 
to DMEM containing 1% BSA and without antibiotics. Basal promoter activity and 
responsiveness to presence of single fatty acids or their combinations were tested during 
a 23 h treatment interval.  
 
Treatments 
Fatty acids C16:0, C18:0, C18:3n-3 cis (Sigma-Aldrich Corp.) were bound to 
BSA (Probumin; Millipore, Billerica, MA) in a 4:1 molar ratio as described previously 
(Berry et al., 1991). Cells at 80% confluence were cultured in DMEM and exposed for 23 
h to either 1% BSA (no addition control), or to 1.0 mM individual fatty acid (bound to 
BSA), or to combinations of fatty acids in 25:75, 50:50, or 75:25 molar ratios from 
combinations of C16:0: C18:3n-3 cis or C18:0: C18:3n-3 cis. Total fatty acid 
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concentration in each combination was 1.0 mM and total BSA concentration was 1%. 
Treatments were applied in triplicate to three cell replicates. 
 
Luciferase Activity 
Following 23 h exposure to treatments, media was removed by aspiration and 
cells were rinsed with ice-cold 1x PBS and harvested in 80 µL 1 × passive lysis buffer 
(Promega, Madison, WI). Cells were removed to a 0.65 mL microcentrifuge tube and 
stored at -20°C until further processing. Luciferase activity in 20 μL of cell lysates was 
initiated by the addition of 100 μL of firefly luciferase detection reagent followed by 
addition of 100 μL of Renilla luciferase detection agent (Promega, Madison, WI). 
Luminescence was quantified using a Tecan GENios Pro spectrofluorometer with 
Magellan 5.0 software (Tecan, Research Triangle Park, NC). Data were normalized for 
transfection efficiency by dividing the relative light units detected for firefly luciferase by 
the corresponding Renilla luciferase relative light units (firefly: Renilla) for each well. 
Activity of bovine PCP1 or bovine PCP1 truncations for each treatment was normalized 




Data were analyzed for normality or error variances using the Univariate 
procedure of SAS 9.3 (SAS Institute Inc., Cary, NC). Analyses of variance was 
performed using the Proc Mixed procedure of SAS. The model accounted for the fixed 
effects of treatment and the random effects of cell replicate. Means were considered 
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different when P < 0.05 and tended to differ if 0.05 ≤ P ≤ 0.10. Tukey-Kramer 
studentized adjustments were used to separate treatment means. Data are reported as least 
squares means with associated standard errors.  
 
In Silico Promoter Sequence Analysis 
Bovine PCP1 sequence (-1002/+3) was analyzed using the PROMO virtual 
laboratory of ALGGEN, which utilizes TRANSFAC version 8.3 (Messeguer et al., 2002; 
Farré et al., 2003). The search parameters were limited to liver specific factors, high-
quality matrices, and set to minimize false positives. 
 
 
RESULTS AND DISCUSSION 
 
The MDBK cell line is utilized in the current study to examine the effects of 
saturated and unsaturated fatty acids on the activity of bovine PCP1. Previous research 
supports the use of the MDBK cell model through similarities between transcriptomes of 
the cell line and liver samples from periparturient dairy cows and responsiveness to fatty 
acids (Bionaz et al., 2008a,b; Thering et al., 2009; White et al., 2012).  
Bovine PC contains three promoters which give rise to six 5’ UTR variants (Agca 
et al., 2004; Hazelton et al., 2008). Development of a novel quantitative real-time RT-
PCR multiplex assay confirmed the correlation between transcript abundance and 
transcription rate for bovine 5’ UTR variants (White et al., 2011a). Fatty acid treatments 
created to mimic circulating nonesterified fatty acid (NEFA) profiles around calving or 
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during induced fatty liver increased expression of PC 5’ UTR variant products of bovine 
PCP1 in MDBK cells (White et al., 2012). This response was not seen after treatment 
with fatty acid profiles representing the pre- or postpartum period, nor was a response 
seen in 5’UTR variants of PCP2 or PCP3 (White et al., 2012).  
The current study utilized the pGL3-luciferase family of promoter constructs. The 
negative control was the promoterless parent vector, pGL3-Basic and the pGL3-SV40 
Promoter served as the positive control. The positive control pGL3-SV40 Promoter drove 
luciferase expression by almost 4 fold relative to pGL3-Basic (P < 0.05; Figure 4.1). 
Bovine PCP1(-1002_+3), as well as any of the examined 5’ bovine PCP1 truncations, were 
able to drive luciferase expression at least 1.5 fold compared to the pGL3-Basic 
promoterless negative control (P < 0.05; Figure 4.1). Bovine PCP1(-773_+3) and bovine 
PCP1(-222_+3)-coupled expression did not differ (P > 0.10) from pGL3-SV40 Promoter-
driven luciferase expression (Figure 4.1). Bovine PCP1(-494_+3) drove luciferase 
expression and did not differ (P > 0.10) from bovine PCP1(-1002_+3)-coupled luciferase 
expression. 
To examine the effects of single fatty acids on bovine PCP1(-1002_+3) activity, 
MDBK cells transfected with bovine PCP1(-1002_+3) were exposed for 23 h to either 1% 
BSA DMEM, or to 1.0 mM C16:0, C18:0, or C18:3n-3 cis. Response in promoter activity 
was normalized to activity of pGL3-Basic promoterless vector (Figure 4.2). Cells 
exposed to either C16:0 or C18:3n-3 cis alone elicited a significant (P < 0.05) increase in 
bovine PCP1(-1002_+3) activity (Figure 4.2). Treatment with C18:3n-3 cis alone caused a 
significantly greater increase (P < 0.05) in promoter activity compared to C16:0 alone, 
indicating a greater magnitude of response to C18:3n-3 cis alone (Figure 4.2).  
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Bovine PCP1 was further evaluated to determine the effects of fatty acid 
treatments on activity of bovine PCP1 5’ serial truncations. Compared to bovine PCP1(-
1002_+3), bovine PCP1(-773_+3) exhibited significantly greater (P < 0.05) activity relative to 
control incubations in 1% BSA DMEM, or after exposure to 1.0 mM C18:3n-3 cis 
(Figure 4.2). Bovine PCP1(-494_+3) showed a decreased (P < 0.05) response to C18:3n-3 
cis compared to bovine PCP1(-1002_+3), and response of bovine PCP1(-494_+3) to other single 
fatty acids or control did not differ from bovine PCP1(-1002_+3) response. In contrast, 
bovine PCP1(-222_+3) exhibited increased (P < 0.05) activity, compared to bovine PCP1(-
1002_+3), after exposure to control 1% BSA DMEM, C16:0, C18:0, or C18:3n-3 cis (Figure 
4.2). Results presented here indicate potential for C18:3n-3 cis-induced response in 
bovine PCP1(-1002_+3), bovine PCP1(-773_+3), and bovine PCP1(-222_+3) truncation regions, 
and the potential for C16:0 or C18:0-induced response in bovine PCP1(-222_+3).  
Previously, expression of bovine PCP1 showed a linear decrease in response to 
increasing concentrations (from 0.25 to 1.0 mM) of C18:0 when bovine PCP1 truncations 
were transfected into H4IIE rat hepatoma cells (White et al., 2011c). Results from 
previous studies demonstrate that the activity of bovine PCP1 is repressed after exposure 
to 1.0 mM C18:0, regardless of the bovine PCP1 truncation, indicating a C18:0-
responsive region in within the bovine PCP1(-222_+3) (White et al., 2011c), which is in 
agreement with current findings. When compared to PC mRNA expression data in 
response to these same fatty acid treatment ratios (CHAPTER 2), the bovine PCP1 
activity data presented in the current study do not parallel the repression caused by 
saturated fatty acids compared to control treatments. Because such dramatic changes are 
seen in mRNA expression, without similar patterns in promoter activity, this suggests that 
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other factors, such as mRNA degradation or stability, are influenced by the presence of 
saturated fatty acids and independent experiments are necessary to confirm these effects. 
Activity of bovine PCP1 was significantly increased with exposure to serum from 
feed-restricted, compared to control, cows when bovine PCP1(-1002_+3) was transfected 
into the H4IIE rat hepatoma cell line (White et al., 2011b). Taken together with previous 
data showing an increase in PC mRNA during feed restriction in dairy cows (Velez and 
Donkin, 2005), and that bovine PC enzyme activity is directly correlated with PC mRNA 
expression (Greenfield et al., 2000), the potential influence of circulating factors in the 
serum from feed-restricted cows on PC activity emerges. Modifying the serum from 
control cows to contain increased concentrations of fatty acids, in proportion to their 
presence in serum from feed-restricted cows, elicited an increase in bovine PCP1 activity 
compared with exposure to serum from feed-restricted cows (White et al., 2011b). Data 
reported in the current study supports the regulation of bovine PCP1 by fatty acids and 
extends these observations to the direct influence of C16:0, C18:0, and C18:3n-3 on 
bovine PCP1 activity.  
During the transition period, or the 6-wk period surrounding calving in dairy 
cows, the predominate plasma NEFA profile consists mainly of C16:0, C18:0, and C18:1 
fatty acids (Rukkwamsuk et al., 1999). During this time, C18:0 plasma levels increase 
while C18:1 levels are similar pre- or postpartum (Rukkwamsuk et al., 1999; Douglas et 
al., 2007). Levels of C16:0 and C18:1 increase in liver of dairy cows that have been 
induced with fatty liver, compared to control animals, mainly due to release of these fatty 
acids from adipose tissue lipolysis (Rukkwamsuk et al., 2000). The fatty concentrations 
in the current experiment (1.0 mM) are similar in magnitude to total circulating NEFA 
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levels at parturition in dairy cows (Rukkwamsuk et al., 1999). Although treatments with a 
single fatty acid are not realistic in a physiological setting, previous research that has 
examined the effect of serum from control and feed restricted cows on bovine PCP1 
activity (White et al., 2011b) indicates induction of PC, but the role of specific fatty acids 
in this regard was unclear. Data from the current study indicates that the increase in PC 
mRNA is associated with location-specific promoter activation of bovine PCP1 by 
C18:3n-3 cis.  
To further examine the interplay for saturated or unsaturated fatty acids on PC 
gene expression, and to more closely mimic physiological fatty acid profiles, the effects 
of treatment combinations of saturated and unsaturated fatty acids were interrogated 
using nested 5’ deletions of bovine PCP1. Treatment with 0.75:0.25, 0.50:0.50, or 
0.25:0.75 C16:0: C18:3n-3 cis increased (P < 0.05) activity of bovine PCP1(-773_+3), 
compared to activity of bovine PCP1(-1002_+3) (Figure 4.3). Similarly, treatment with 
0.75:0.25, 0.50:0.50, or 0.25:0.75 C16:0: C18:3n-3 cis increased (P < 0.05) activity of 
bovine PCP1(-222_+3), compared to activity of bovine PCP1(-1002_+3) (Figure 4.3). Similar to 
treatment with C18:3n-3 cis alone, treatments of 0.50:0.50 or 0.25:0.75 C16:0: C18:3n-3 
cis elicited a significant (P < 0.05) decrease in truncated promoter activity compared to 
activity of bovine PCP1(-1002_+3) within each treatment (Figure 4.3). Activity of bovine 
PCP1(-494_+3) decreased (P < 0.05), compared to bovine PCP1(-1002_+3) activity after 
exposure to 0.50:0.50, or 0.25:0.75 C16:0: C18:3n-3 cis (Figure 4.3). Similar response 
patterns were seen over all bovine PCP1 truncations with treatment combinations of 
C18:0: C18:3n-3 cis (Figure 4.4). These data again point to both activating and 
suppressive influences of fatty acids on different bovine PCP1 regions. Because response 
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to inclusion, at any level, of C18:3n-3 cis increased promoter activity of bovine PCP1(-
773_+3) or bovine PCP1(-222_+3) compared to activity of bovine PCP1(-1002_+3), these data 
support the potential for response elements of unsaturated fatty acids or fatty acid ligands 
in this region. 
Transcriptional regulation of genes by long chain fatty acids occurs through a 
complement of transcription factors, including PPARα, hepatocyte nuclear factor 
(HNF)4, and LXR (Pawar and Jump, 2003; Jump, 2013). Because primary regulators of 
these transcription factors include C18- and C20-carbon fatty acids (Jump, 2013), 
changes in the circulating NEFA profile concurrent with feed restriction or during 
parturition in dairy cows are of particular interest. 
Ligands capable of binding to PPAR include fatty acids, peroxisome proliferators, 
antidiabetic, and hypolipidemic drugs (Schoonjans et al., 1996). Activated, ligand-bound 
PPAR forms a heterodimer with retinoid X receptor before biding to response elements. 
In liver, the predominant form is PPARα, which is linked to both fatty acid β-oxidation 
and lipid metabolism (Lee et al., 1995). Bovine hepatocyte isolations from 7-wk-old 
calves given treatment of a PPARα agonist for 5 d showed increased conversion of C16:0 
to CO2 compared to control (Litherland et al., 2010). The activity of bovine PCP1 is 
upregulated through PPARα agonists, and suppressed by C18:0 in rat hepatoma cells 
transfected with bovine PCP1 (White et al., 2011c). Furthermore, responsiveness of 
bovine PCP1 is regulated by serum fatty acid profiles that are altered during feed 
restriction and negative energy balance (White et al., 2011b), but the dominance of 
control of saturated and unsaturated fatty acids, and the concentration required to elicit a 
response have not yet been defined. 
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Sterol regulatory element-binding proteins are a family of transcription factors 
intricately involved in both lipogenesis and cholesterol synthesis. The predominant 
isoform in liver, SREBP-1c, is increased during over nutrition or with increased 
circulating glucose concentrations in rodents (Horton et al., 1998), and is downregulated 
by polyunsaturated fatty acids (Shimano, 2009). Recently, SREBP-1c mediated signaling 
has been implicated in postprandial increase in C18:0 associated with insulin resistance in 
diabetic humans and rats (Chu et al., 2013). Liver X receptors are activated by oxysterols 
and also activate the expression of SREBP-1c (Yoshikawa et al., 2001). This link 
between cholesterol metabolism and fatty acid metabolism has been further solidified as 
PPARα and PPARα agonists have been shown to reduce the binding LXR to LXR 
response elements in the SREBP-1c promoter by reducing LXR dimerization to retinoid 
X receptor (Yoshikawa et al., 2003). This crosstalk between PPARα and LXR to limit 
SREBP-1c supports the potential for interplay between saturated and unsaturated fatty 
acids to influence gene expression and subsequent cellular lipid metabolism. 
In silico analysis of the bovine PCP1 using the PROMO virtual laboratory of 
ALGGEN, which utilizes TRANSFAC version 8.3 (Messeguer et al., 2002; Farré et al., 
2003), revealed several putative binding sites for both PPARα and SREBP (Figure 4.5). 
Putative PPARα binding sites are identified at -989 to -933, -401 to -395, and from -73 to 
-67 bp relative to bovine PCP1(-1002_+3) transcription start site (TSS; Figure 4.5). Putative 
SREBP sites are identified at -411 to -397 bp relative to bovine PCP1(-1002_+3) TSS for 
SREBP-1 and at -665 to -654 and -408 to -398 bp relative to bovine PCP1(-1002_+3) TSS 
for SREBP-2 (Figure 4.5). Finally, a putative LXR site is identified at -74 to -68 bp 
relative to bovine PCP1(-1002_+3) TSS (Figure 4.5). Abbreviations for additional putative 
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transcription factors identified in Figure 4.5 are listed in Table 4.1. Promoter truncation 
activity in response to fatty acids treatments supports the potential for activation by the 
presence of C18:3n-3 cis of bovine PCP1(-1002_+3), and bovine PCP1(-222_+3); regions which 
contain a putative PPARα binding site. The lack of response to C18:3n-3 cis inclusion for 
bovine PCP1(-494_+3) may be attributed to the presence of putative SREBP-1 and SREBP-2 
sites, or the potential for crosstalk between these transcription factors and their binding 
sites. This hypothesis is further supported by the upregulation of bovine PCP1 through 
PPARα agonists, and suppression by C18:0 in transfected rat hepatoma cells (White et 
al., 2011c), and by the potential for crosstalk between PPARα and LXR to reduce 
SREBP-1c-induced signaling (Yoshikawa et al., 2003). Taken together, the data reported 
in the current study support the involvement of both PAPRα and SREBP as the 




Data presented here indicates several potential fatty acid-responsive regions of 
bovine PCP1. Specifically, that increased activity of bovine PCP1(-1002_+3), and bovine 
PCP1(-222_+3) in response to inclusion of C18:3n-3 cis may be due to potential signaling 
through putative PPARα binding sites identified in these regions. Furthermore, repression 
of bovine PC may be linked to putative SREBP binding sites within region -494 through 
+3 of bovine PCP1. Additional research is necessary to confirm involvement of these 
transcription factors in regulating bovine PC expression and to determine the precise 
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Figure 4.1. Basal promoter activity of bovine pyruvate carboxylase promoter 1 (PCP1) 
and bovine PCP1 regions serially truncated from the 5' end. The longest construct, bovine 
PCP1(-1002_+3), and serial 5' truncations, bovine PCP1(-773_+3), bovine PCP1(-494_+3), and 
bovine PCP1(-222_+3), were individually ligated to Firefly luciferase reporter and 
transefected in Madin-Darby bovine kidney (MDBK) cells. Cotransfection of Renilla 
pRL-CMV luciferase plasmid was used to normalize transfection efficiency. Five hours 
after transfection, cells were incubated in DMEM containing 1% BSA without antibiotics 
for 23 h and luciferase activities were then determined in cell lysates. The pGL3-Basic is 
promoterless and used as a negative control, and the pGL3-SV40 Promoter served as 





















luciferase. Data are reported as least squares means with associated standard errors. 
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Figure 4.2. Effect of 23 h single fatty acid treatments, C16:0, C18:0, or C18:3n-3 cis, on 
induction of bovine pyruvate carboxylase promoter 1 (PCP1) and bovine PCP1 regions 
serially truncated from the 5’ end in Madin-Darby bovine kidney (MDBK) cells. The 
longest construct, bovine PCP1(-1002_+3), and serial 5' truncations, bovine PCP1(-773_+3), 
bovine PCP1(-494_+3), and bovine PCP1(-222_+3), were individually ligated to Firefly 



























CMV luciferase plasmid was used to normalize transfection efficiency. Five hours after 
transfection, cells were exposed to single fatty acid treatments (C16:0, C18:0, or C18:3n-
3 cis). All treatments totaled 1.0 mM in Dulbecco’s Modified Eagle’s Medium (DMEM) 
with 1% BSA. Control treatment is DMEM with 1% BSA and no additional fatty acid. 
Promoter activity is expressed as ratio of Firefly luciferase to Renilla luciferase, 
normalized to pGL3-Basic promoterless negative control basal expression. Data are 
reported as least squares means with associated standard errors. Within treatment, 
asterisk indicates a significant (P < 0.05) difference from bovine PCP1(-1002_+3). Within 
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Figure 4.3. Effect of 23 h C16:0: C18:3n-3 cis fatty acid treatments on induction of 
bovine pyruvate carboxylase promoter 1 (PCP1) and bovine PCP1 regions serially 
truncated from the 5’ end in Madin-Darby bovine kidney (MDBK) cells. The longest 
construct, bovine PCP1(-1002_+3), and serial 5' truncations, bovine PCP1(-773_+3), bovine 
PCP1(-494_+3), and bovine PCP1(-222_+3), were individually ligated to Firefly luciferase 




































luciferase plasmid was used to normalize transfection efficiency. Five hours after 
transfection, cells were exposed to fatty acid combinations in 25:75, 50:50, or 75:25 
ratios for the fatty acid combinations of C16:0: C18:3n-3 cis. All treatments totaled 1.0 
mM in Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% BSA. Control treatment 
is DMEM with 1% BSA and no additional fatty acid. Promoter activity is expressed as 
ratio of Firefly luciferase to Renilla luciferase, normalized to pGL3-Basic promoterless 
negative control basal expression. Data are reported as least squares means with 
associated standard errors. Within treatment, asterisk indicates a significant (P < 0.05) 
difference from bovine PCP1(-1002_+3). Within bovine PCP1 truncation, means without a 
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Figure 4.4. Effect of 23 h C18:0: C18:3n-3 cis fatty acid treatments on induction of 
bovine pyruvate carboxylase promoter 1 (PCP1) and bovine PCP1 regions serially 
truncated from the 5’ end in Madin-Darby bovine kidney (MDBK) cells. The longest 
construct, bovine PCP1(-1002_+3), and serial 5' truncations, bovine PCP1(-773_+3), bovine 
PCP1(-494_+3), and bovine PCP1(-222_+3), were individually ligated to Firefly luciferase 




































luciferase plasmid was used to normalize transfection efficiency. Five hours after 
transfection, cells were exposed to fatty acid combinations in 25:75, 50:50, or 75:25 
ratios for the fatty acid combinations of C18:0: C18:3n-3 cis. All treatments totaled 1.0 
mM in Dulbecco’s Modified Eagle’s Medium (DMEM) with 1% BSA. Control treatment 
is DMEM with 1% BSA and no additional fatty acid. Promoter activity is expressed as 
ratio of Firefly luciferase to Renilla luciferase, normalized to pGL3-Basic promoterless 
negative control basal expression. Data are reported as least squares means with 
associated standard errors. Within treatment, asterisk indicates a significant (P < 0.05) 
difference from bovine PCP1(-1002_+3). Within bovine PCP1 truncation, means without a 



























Figure 4.5. A diagram of bovine pyruvate carboxylase promoter 1 (PCP1; -1002/+3 bp 
relative to transcription start site) and putative transcription factor binding sites. Putative 
transcription factor binding sites were identified using the PROMO virtual laboratory of 
ALGGEN, which utilizes TRANSFAC version 8.3 (Messeguer et al., 2002; Farré et al., 
2003). The search parameters were limited to liver specific factors, high-quality matrices, 
and set to minimize false positives. Abbreviations for common transcription factors are 
listed in Table 4.1. 
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Table 4.1. Abbreviations for common transcription factors whose putative binding sites 
are identified in bovine pyruvate carboxylase promoter 1. Putatuve transcription factors 
were identified using the PROMO virtual laboratory of ALGGEN, which utilizes 
TRANSFAC version 8.3 (Messeguer et al., 2002; Farré et al., 2003). 
Abbreviation Common name 
ATF Activating transcription factor 
ATF-4 Activating transcription factor 4  
CAR Constitutive androstane receptor 
C-Jun Jun proto-oncogene 
COUP Chicken ovalbumin upstream transcription factor 
CREB cAMP responsive element binding protein 
Ebox Viral oncogene homolog 
FXR Farnesoid X receptor 
GR Glucocorticoid receptor 
HNF1α Hepatocyte nuclear factor-1α 
HNF1β Hepatocyte nuclear factor-1β 
LRH1 Liver receptor homologous protein 
LXR Liver X receptor 
p50 p50; nuclear factor κB light chain gene enhancer 
p65 p65; nuclear factor κB light chain gene enhancer 
PPARα Peroxisome proliferator-activated receptor α 
PXR Pregnane X receptor 
RAR Retinoic acid receptor  
RXR Retinoid X receptor 
SREBP1 Sterol regulatory element binding protein 1 
SREBP2 Sterol regulatory element binding protein 2 
USF Upstream specificity factor 
USF1 Upstream specificity factor 1 




CHAPTER 5.  CONCLUSIONS AND IMPLICATIONS 
 
Pyruvate carboxylase (PC) is responsible for the synthesis of oxaloacetate (OAA) 
from pyruvate, a reaction critical to both the anaplerotic push and cataplerotic pull of 
carbons through the tricarboxylic acid (TCA) cycle. The pool of available OAA appears 
to be critical in determining the oxidative capacity of the cell and the maintenance of this 
pool is a function of the balance of anaplerotic and cataplerotic processes in the cell. If 
the pull of carbons to gluconeogenesis, namely through actions of the enzyme 
phosphoenolpyruvate carboxykinase (PCK), is less than the supply of carbons to the TCA 
cycle by PC, then the oxidative capacity of the cell should be increased, yielding 
increased oxidation of acetyl-CoA. The study of factors, including fatty acids, which 
influence PC activity and subsequent OAA supply is necessary for a better understanding 
of the relationship between carbohydrate and lipid metabolism. The central hypothesis of 
this dissertation is that the ratio of the most prevalent circulating nonesterified saturated 
and unsaturated fatty acids in dairy cows regulates PC flux and subsequent fatty acid 
metabolism. The objectives of this dissertation were to determine: 1) the response of PC 
mRNA to the copresence of the most abundant saturated and unsaturated fatty acids 
present in circulation in periparturient dairy cows; 2) the direct effects of these saturated 
and unsaturated fatty acids, and their combinations, on the cellular oxidation of fatty 
139 
acids, and the potential relationship to PC; 3) the effects of the copresence of these 
saturated and unsaturated fatty acids on the transcriptional activity of bovine PC proximal 
promoter (PCP1). 
Characterization of PC response to the copresence of saturated and unsaturated 
fatty acids was tested in a bovine kidney cell line and in bovine primary hepatocytes. The 
fatty acids tested included C16:0, C18:0, C18:1n-9 cis, and C18:3n-3 cis, as these are the 
predominant circulating fatty acids in periparturient dairy cows. There is a significant 
depression of PC mRNA expression after exposure to either C16:0 or C18:0 alone in 
bovine kidney cells; this depression is ameliorated by inclusion of C18:3n-3 cis in the 
kidney cell model. Monounsaturated C18:1n-9 cis did not elicit a change in PC mRNA 
expression, indicating that degree of fatty acid saturation is key for influence on PC. 
Bovine primary hepatocytes displayed a similar, though not significantly different, 
numerical pattern in response to fatty acid treatments. In contrast to data from bovine 
kidney cells, PC expression increased nearly two-fold with exposure to C18:3n-3 cis 
alone in primary hepatocytes. This discrepancy may reflect differences in sensitivity to 
fatty acid exposure between cell types, cell or in vivo conditions prior to initiation of the 
experiments, or both.  
To determine if changes in PC mRNA expression were related to oxidative 
capacity of cell, substrate flux was determined following exposure to the copresence of 
saturated and unsaturated fatty acids. Fatty acid flux to CO2 was correlated to PC mRNA 
expression, while fatty acid substrate flux to ketone body production, representing 
incomplete oxidation, was less evident but still tended to correlate with PC mRNA 
expression. Substrate flux representing either complete oxidation to CO2 or partial 
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oxidation to ketone bodies was depressed by saturated fatty acids and these fluxes both 
correlate with PCK1 mRNA expression. Activation of enzymes involved in ketogenesis 
or gluconeogenesis, including PCK, may be tempered by inclusion of factors that 
specifically activate PC, while only maintaining PCK to promote cellular oxidative 
capacity.  
Activity of bovine PCP1 was directly examined in response to saturated and 
unsaturated fatty acid treatments using a promoter reporter construct and nested 5’ serial 
promoter truncations. Bovine PCP1 activity increased after exposure to either unsaturated 
C18:3n-3 cis or saturated 16:0 treatments. Promoter truncation experiments evaluating 
specific regions of bovine PCP1 reveal a region between -773 to -494 bp (bovine PCP1(-
773_+3)) relative to transcription start site (TSS) that is highly responsive to fatty acids. In 
silico analysis of bovine PCP1 showed several transcription factor binding site consensus 
sequences within this region. Bovine PCP1 response to the presence of C18:3n-3 cis may 
be due to potential signaling through peroxisome proliferator activated receptor (PPAR) α 
at potential binding sites within bovine PCP1(-1002_+3) or within bovine bovine PCP1(-
222_+3). A lack of response to C18:3n-3 cis of bovine PCP1(-494_+3) may be linked to sterol 
regulatory element binding proteins (SREBP) binding sites, which are responsive to 
saturated fatty acids. A more rigorous evaluation of these putative transcription factor 
binding sites is necessary to definitively assign these elements to control of the bovine PC 
gene.  
Taken together, these data indicate that bovine PC mRNA expression is 
responsive to fatty acids through changes in the activity of the PC proximal promoter. 
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Furthermore, PC mRNA expression is correlated with complete substrate oxidation to 
CO2, supporting the potential role for PC flux to promote cellular oxidative capacity.  
This new research adds to our knowledge of the balance between anaplerosis and 
cataplerosis and the response to metabolic conditions by PC. This information provides 
new insight that may be applied to better understand the physiological response of dairy 
cows to the onset of lactation and potential changes in hepatic oxidative capacity during 
this interval. Nonesterified fatty acids (NEFA) that are mobilized during periods of 
negative energy balance, including the periparturient period in dairy cattle, are taken up 
by liver and subsequently are either completely or partially oxidized. The current work 
confirms that the fates of NEFA are determined, in part, by PC activity thus promoting 
the pull of acetyl-CoA through the TCA cycle for complete oxidation (Figure 5.1). 
Because it is also well established that acetyl-CoA serves as an allosteric regulator of PC, 
and the current data effectively demonstrate the influence that fatty acids have in 
determining both PC mRNA expression and substrate pull towards oxidation. If the 
availability of acetyl-CoA is greater than the supply of OAA, excess acetyl-CoA will be 
incompletely oxidized to ketone bodies. This puts a periparturient dairy cow at increased 
risk for developing ketosis if PC activity cannot maintain the OAA pool. Novel findings 
from the current research illustrate the pivotal role for PC in the anaplerotic generation of 
TCA cycle intermediates, and emphasize the importance of identifying potential factors 
that specifically promote PC flux while only maintaining but not expanding the pull, by 
PCK, of carbons for gluconeogenesis. If the ratio of PCK : PC increases, carbon flux will 
be promoted to gluconeogenesis rather than into the TCA cycle. Bovine PCP1 is 
responsive to the same physiological factors, primarily circulating fatty acids, which 
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dramatically increase during the negative energy balance experienced by dairy cattle 
during the periparturient period.  
Data in this dissertation demonstrates for the first time that the response of PC 
mRNA expression, through bovine PCP1 promoter activity, is dependent on the ratio of 
saturated to unsaturated fatty acids, with polyunsaturated n-3 fatty acid having strong 
stimulatory influence. Additional work is necessary to translate this fundamental 
discovery to application but the potential exists, based on the present data, to program 
hepatic metabolism in transition cows towards enhanced capacity to metabolize NEFA in 
favor of complete and partial oxidation and alleviate the potential for hepatic lipid 
accumulation that is prevalent in the industry. Manipulation of the ratio of fatty acids in 
plasma through feeding management strategies during critical periods of metabolic stress, 
if successful, may favor a shift in hepatic metabolism that would aid in the prevention of 
metabolic disorders in dairy cows. While the present work has focused on lipid 
metabolism in gluconeogenic tissues, it will be critical going forward to determine the 
impact of manipulating fatty acid profiles more holistically in the dairy cow and the 




Figure 5.1. A diagram of fatty acid metabolism in dairy cows and impact of pyruvate 
carboxylase (PC). Nonesterified fatty acids (NEFA) are mobilized from adipose tissue 
reserves during periods of negative energy balance, including the periparturient period in 
dairy cows. Metabolized NEFA can have several fates, including esterification and 
deposition as liver triglycerides (TG), partial oxidation, yielding ketones, or complete 
oxidation of acetyl-CoA to ATP and CO2. The capacity of the tricarboxylic acid (TCA) 
cycle to oxidize acetyl-CoA is dependent upon the available pool of oxaloacetate (OAA). 
The anaplerotic regeneration of TCA cycle intermediates is supported by PC, which 
catalyzes the conversion of pyruvate to OAA. If PC activity increases, supply of OAA to 
the TCA cycle can be increased, only if the activity of phosphoenolpyruvate 
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carboxykinase (PCK) is maintained, but not concurrently increased. Expression of PC 
mRNA is, in part, regulated by the profile of fatty acids present, with specific effects of 
saturated fatty acids (C16:0 or C18:0) to depress PC mRNA expression, which can be 
recovered with exposure to polyunsaturated C18:3n-3 cis. This change in PC mRNA 
expression directly correlates to the partitioning of C16:0 to CO2, or a laboratory 
measurement of ketones. Fatty acids may act to further regulate cellular metabolism by 
activating transcription factors with response elements in the bovine PC proximal 
promoter, further potentiating the response of PC to fatty acids. Cytosolic 
phosphoenolpyruvate carboxykinase, PCK1; mitochondrial phosphoenolpyruvate 
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